Form 10-Q - Quarterly report [Sections 13 or 15(d)]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2024

 

OR

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM _______________ TO _______________

 

COMMISSION FILE NUMBER: 000-55079

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

 

Nevada		27-2343603
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification Number)
10800 Galaxie Avenue Ferndale, MI		48220
(Address of principal executive offices)		(Zip code)

 

[phone]

(Registrant’s telephone number, including area code)

 

not applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

	Large accelerated filer	☐	Accelerated filer	☐
	Non-accelerated filer	☒	Smaller reporting company	☒
			Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 11,911,671,042 shares of common stock were issued and outstanding as of September 30, 2024.

 

 

 

 

Table of Contents

 

		PAGE
PART I	FINANCIAL INFORMATION
ITEM 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of August 31, 2024 and February 28, 2024 (Unaudited)	3
	Condensed Consolidated Statements of Operations for the Three Months and Six Months Ended August 31, 2024 and 2023 (Unaudited)	4
	Condensed Consolidated Statements of Stockholders’ Deficit for the Six Months Ended August 31, 2024 and 2023 (Unaudited)	5-6
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended August 31, 2024 and 2023 (Unaudited)	7
	Notes to the Consolidated Financial Statements (Unaudited)	8-27
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	33
ITEM 4.	Controls and Procedures	33
PART II	OTHER INFORMATION
ITEM 1.	Legal Proceedings	34
ITEM 1A.	Risk Factors	34
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
ITEM 3.	Defaults Upon Senior Securities	34
ITEM 4.	Mine Safety Disclosures	34
ITEM 5.	Other Information	34
ITEM 6.	Exhibits	35
SIGNATURES		36

 

- 2 -

Table of Contents

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

		August 31, 2024 (unaudited)				February 29, 2024*
ASSETS
Current assets:
Cash		$	543,133			$	105,926
Accounts receivable, net			650,293				756,084
Share proceeds receivable			280,783				—
Device parts inventory, net			2,063,229				2,131,599
Prepaid expenses and deposits			552,667				622,957
Total current assets			4,090,105				3,616,566
Operating lease asset			1,070,511				1,139,188
Revenue earning devices, net of accumulated depreciation of $1,513,990 and $952,844, respectively			3,649,389				2,480,002
Fixed assets, net of accumulated depreciation of $434,043 and $349,878, respectively			258,183				268,075
Trademarks			31,224				27,080
Convertible note receivable			50,000				—
Investment at cost			50,000				50,000
Security deposit			15,880				15,880
Total assets		$	9,215,292			$	7,596,791
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses		$	1,882,487			$	2,032,707
Advances payable- related party			1,594				1,594
Customer deposits			363,572				73,702
Current operating lease liability			225,348				237,653
Current portion of deferred variable payment obligation			1,315,264				904,377
Loan payable - related party			279,589				257,438
Deferred compensation for CEO			204,091				538,767
Current portion of loans payable, net of discount of $88,993 and $688,598			23,373,618				13,190,882
Vehicle loan - current portion			38,522				38,522
Current portion of accrued interest payable			9,396,626				4,440,009
Total current liabilities			37,080,711				21,715,651
Non-current operating lease liability			837,844				889,360
Loans payable, net of discount of $413,071 and $4,118,332, respectively			9,287,664				14,798,532
Deferred variable payment obligation			2,525,000				2,525,000
Incentive compensation plan payable			2,500,000				2,500,000
Accrued interest payable			2,454,436				5,367,805
Total liabilities			54,685,655				47,796,348
Commitments and Contingencies
Redeemable Preferred Stock (Temporary Equity):
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly, $1,200 stated value, 5,000 shares authorized, 0 and 0 shares issued and outstanding at August 31, 2024 and February 29, 2024, respectively			—				—
Stockholders’ deficit:
Preferred Stock, undesignated; 15,535,000 shares authorized; no shares issued and outstanding at August 31, 2024 and February 29, 2024, respectively			—				—
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at August 31, 2024 and February 29, 2024, respectively			—				—
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively			3,350				3,350
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,533 shares issued and outstanding, respectively			2,513				2,533
Common Stock, $0.00001 par value; 15,000,000,000 shares authorized 11,706,671,042 and 9,238,750,958 shares issued, issuable and outstanding, respectively			117,067				92,388
Additional paid-in capital			99,993,641				92,565,513
Preferred stock to be issued			99,086				99,086
Accumulated deficit			(145,686,020	)			(132,962,427	)
Total stockholders’ deficit			(45,470,363	)			(40,199,557	)
Total liabilities and stockholders’ deficit		$	9,215,292			$	7,596,791

 

*	Derived from audited information

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

- 3 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

		Three Months Ended				Three Months Ended				Six Months Ended				Six Months Ended
		August 31, 2024				August 31, 2023				August 31, 2024				August 31, 2023
Revenues		$	1,344,183			$	386,363			$	2,526,983			$	771,571
Purchases and overhead			544,965				89,014				840,558				180,525
Depreciation and amortization			240,000				111,575				441,873				208,539
Cost of Goods Sold			784,965				200,589				1,282,431				389,064
Gross Profit			559,218				185,774				1,244,552				382,507
Operating expenses:
Research and development (Note 9)			677,410				794,548				1,318,120				1,686,305
General and administrative			2,324,953				2,294,471				5,045,144				4,414,902
Depreciation and amortization			107,762				79,466				203,438				150,444
Operating lease cost and rent			62,967				62,541				124,980				125,083
Total operating expenses			3,173,092				3,231,026				6,691,682				6,376,734
Loss from operations			(2,613,874	)			(3,045,252	)			(5,447,130	)			(5,994,227	)
Other income (expense), net:
Interest expense			(1,309,929	)			(1,753,216	)			(2,671,032	)			(3,359,432	)
Gain (loss) on settlement of debt			(6,520	)			38,740				(6,520	)			38,740
Total other expense net			(1,316,449	)			(1,714,476	)			(2,677,552	)			(3,320,692	)
Net loss		$	(3,930,323	)		$	(4,759,728	)		$	(8,124,682	)		$	(9,314,919	)
Net loss per share - basic		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Net loss per share - diluted		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Weighted average common share outstanding - basic			11,181,863,976				6,568,957,612				10,531,991,040				6,266,833,467
Weighted average common share outstanding - diluted			11,181,863,976				6,568,957,612				10,531,991,040				6,266,833,467

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

- 4 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

 

		Temporary Equity								Shareholder’s Deficit
		Series B								Series E								Series F																Additional								Total
		Preferred Stock								Preferred Stock								Preferred Stock								Common Stock								Paid-In				Accumulated				Shareholders’
		Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Capital				Deficit				Deficit
Balance at February 28, 2023			—				—				3,350,000			$	3,350				2,533			$	101,619				5,848,741,599			$	58,489			$	80,247,252			$	(112,253,711	)		$	(31,843,001	)
Issuance of shares, net of $81,285 issuance costs			—				—				—				—				—				—				280,929,190				2,809				1,316,100				—				1,318,909
Relative fair value of Series F warrants issued with debt			—				—				—				—				—				—				—				—				947,447				—				947,447
Stock based compensation			—				—				—				—				—				—				—				—				52,721				—				52,721
Net income			—				—				—				—				—				—				—				—				—				(4,555,193	)			(4,555,193	)
Balance at May 31, 2023			—			$	—				3,350,000			$	3,350				2,533			$	101,619				6,129,670,789			$	61,298			$	82,563,520			$	(116,808,904	)		$	(34,079,117	)
Issuance of shares, net of $176,672 issuance costs			—				—				—				—				—				—				903,636,004				9,036				4,787,087				—				4,796,123
Shares as payment for services			—				—				—				—				—				—				6,500,000				65				44,395				—				44,460
Stock based compensation			—				—				—				—				—				—				—				—				50,713				—				50,713
Net income			—				—				—				—				—				—				—				—				—				(4,759,728	)			(4,759,728	)
Balance at August 31, 2023			—			$	—				3,350,000			$	3,350				2,533			$	101,619				7,039,806,793			$	70,399			$	87,445,715			$	(121,568,632	)		$	(33,947,549	)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

- 5 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

 

		Temporary Equity								Shareholder’s Deficit
		Series B								Series E								Series F																Additional								Total
		Preferred Stock								Preferred Stock								Preferred Stock								Common Stock								Paid-In				Accumulated				Shareholders’
		Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Capital				Deficit				Deficit
Balance at February 29, 2024			—				—				3,350,000			$	3,350				2,533			$	101,619				9,238,750,958			$	92,388			$	92,565,513			$	(132,962,427	)		$	(40,199,557	)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024			—				—				—				—				—				—				—				—				—				(4,175,535	)			(4,175,535	)
Issuance of shares, net of $116,046 issuance costs			—				—				—				—				—				—				1,080,166,425				10,802				2,671,791				—				2,682,593
Issuance of Series B Preferred Shares			300				360,000				—				—				—				—				—				—				(82,000	)			—				(82,000	)
Series B Preferred Shares issued as commitment fee			20				24,000				—				—				—				—				—				—				(24,000	)			—				(24,000	)
Series B Preferred shares issued as dividend			2				2,568				—				—				—				—				—				—				(2,568	)			—				(2,568	)
Redemption of Series B Preferred shares			(107	)			(128,856	)			—				—				—				—				—				—				28,856				(28,856	)			—
Stock based compensation			—				—				—				—				—				—				—				—				83,323				—				83,323
Net income			—				—				—				—				—				—				—				—				—				(4,194,359	)			(4,194,359	)
Balance at May 31, 2024			215			$	257,712				3,350,000			$	3,350				2,533			$	101,619				10,318,917,383			$	103,190			$	95,240,915			$	(141,361,177	)		$	(45,912,103	)
Issuance of shares, net of $195,656 issuance costs			—				—				—				—				—				—				1,330,610,802				13,306				4,478,054				—				4,491,360
Debt exchanged for common stock			—				—				—				—				—				—				57,142,857				571				199,429				—				200,000
Series F Preferred Shares exchanged for debt			—				—				—				—				(20	)			(20	)			—				—				(65,793	)			(334,187	)			(400,000	)
Series B Preferred shares issued as dividend			2				2,620				—				—				—				—				—				—				(2,620	)			—				(2,620	)
Redemption of Series B Preferred shares			(217	)			(260,332	)			—				—				—				—				—				—				60,333				(60,333	)			—
Stock based compensation			—				—				—				—				—				—				—				—				83,323				—				83,323
Net income			—				—				—				—				—				—				—				—				—				(3,930,323	)			(3,930,323	)
Balance at August 31,2024			—			$	—				3,350,000			$	3,350				2,513			$	101,599				11,706,671,042			$	117,067			$	99,993,641			$	(145,686,020	)		$	(45,470,363	)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

- 6 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

		Six Months Ended August 31, 2024				Six Months Ended August 31, 2023
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss		$	(8,124,682	)		$	(9,314,919	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization			645,311				358,983
Bad debts expense			11,995				24,730
Inventory provision			111,000				—
Reduction of right of use asset			63,821				58,220
Accretion of lease liability			61,159				66,864
Stock based compensation			166,646				228,434
Amortization of debt discounts			129,333				1,258,198
(Gain) loss on settlement of debt			6,520				(38,740	)
Increase in related party accrued payroll and interest			22,151				54,230
Changes in operating assets and liabilities:
Accounts receivable			93,796				(20,377	)
Prepaid expenses			75,146				(77,410	)
Device parts inventory			(1,823,713	)			(941,261	)
Accounts payable and accrued expenses			6,989				16,775
Customer deposits			289,870				24,798
Deferred compensation for CEO			(505,000	)			—
Operating lease liabilities			(118,383	)			(125,083	)
Current portion of deferred variable payment obligation for payments			410,887				125,457
Accrued interest payable			2,043,248				1,965,885
Net cash used in operating activities			(6,433,906	)			(6,335,216	)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets			(23,724	)			(3,463	)
Acquisition of trademarks			(4,144	)			—
Convertible note receivable			(50,000	)			—
Net cash used in investing activities			(77,868	)			(3,463	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs			6,893,169				6,115,032
Proceeds from loans payable			350,000				1,050,000
Repayment of loans payable			(183,000	)			(254,000	)
Proceeds on issuance of Series B shares			278,000				—
Redemption of Series B shares			(389,188	)			—
Net cash provided by financing activities			6,948,981				6,911,032
Net change in cash			437,207				572,353
Cash, beginning of period			105,926				939,759
Cash, end of period		$	543,133			$	1,512,112
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest		$	185,705			$	9,892
Cash paid for income taxes		$	—			$	—
Noncash investing and financing activities:
Transfer from device parts inventory to revenue earning devices		$	1,781,083			$	889,230
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024		$	4,175,535			$	—
Discount applied to face value of loans		$	—			$	150,000
Exchange of Series F preferred stock for note payable		$	400,000			$	—
Exchange of note payable for common stock		$	200,000			$	—
Series B preferred shares issued as dividend		$	5,188			$	—
Series F warrants issued as part of debt		$	—			$	947,447
Shares issued for services		$	—			$	44,460

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

- 7 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. GENERAL INFORMATION

 

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

 

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

 

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

 

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

 

2. GOING CONCERN

 

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

For the six months ended August 31, 2024, the Company had negative cash flow from operating activities of $6,433,906. As of August 31, 2024, the Company has an accumulated deficit of $145,686,020, and negative working capital of $32,990,606 Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

 

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In July 2024, the Company entered into an equity financing agreement whereby an investor will purchase up to $30,000,000 of the Company’s common stock at a discount over a two-year period. There remains approximately $29 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

 

- 8 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

3. ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K/A as filed on May 29, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices Residential, Inc.. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the six months ended August 31, 2024, are not necessarily indicative of the results that may be expected for the entire year.

 

Use of Estimates

 

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.

 

Reclassifications

 

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

 

Concentrations

 

Loans payable

 

At August 31, 2024 there were $33,163,345 of loans payable, $28,743,506 or 87% of these loans to companies controlled by one individual. At February 29, 2024 there were $32,796,345 of loans payable, $28,540,506 or 87% of these loans to companies controlled by the same individual.

 

Cash

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

 

Accounts Receivable

 

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $48,000 and $68,000 provided as of August 31, 2024 and February 29, 2024, respectively. For the three months ended August 31, 2024, two customers account for 55% of total accounts receivable. For the three months ended August 31, 2023, two customers account for 37% of total accounts receivable.

 

Device Parts Inventory

 

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of August 31, 2024 and February 29, 2024 there was a valuation reserve of $1,070,000 and $959,000, respectively.

 

- 9 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Revenue Earning Devices

 

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

 

Fixed Assets

 

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

  

Computer equipment and software		2 or 3 years
Office equipment		4 years
Manufacturing equipment		7 years
Warehouse equipment		5 years
Tooling		2 years
Demo Devices		4 years
Vehicles		3 years
Leasehold improvements		5 years, the life of the lease

 

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

 

Research and Development

 

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At August 31, 2024 and February 29, 2024, the Company had no deferred development costs.

 

Contingencies

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

Sales of Future Revenues

 

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

 

- 10 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

	●	Does the agreement purport, in substance, to be a sale
	●	Does the Company have continuing involvement in the generation of cash flows due the investor
	●	Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets
	●	Is the investors rate of return is implicitly limited by the terms of the agreement
	●	Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return
	●	Does the investor have recourse relating to payments due

 

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

 

Revenue Recognition

 

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the six months ended August 31, 2024 , two customers accounted for 67% of total revenue (2023- 33%).

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements

 

Leases

 

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

 

- 11 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

 

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

- 12 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

	●	Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
	●	Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 – Inputs that are unobservable for the asset or liability.

 

Measured on a Recurring Basis

 

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

 

		Amount at				Fair Value Measurement Using
		Fair Value				Level 1				Level 2				Level 3
August 31, 2024
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares		$	2,500,000			$	—			$	—			$	2,500,000
February 29, 2024
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares		$	2,500,000			$	—			$	—			$	2,500,000

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

 

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

 

- 13 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Recently Issued Accounting Pronouncements

 

Recently Issued Accounting Standards Not Yet Adopted

 

In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. The Company adopted the standard using a modified retrospective approach. The adjustment to the Company’s accumulated deficit at March 1, 2024 was $4,175,535 with a corresponding adjustment to loans payable.

 

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

 

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

 

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

 

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

		Three Months Ended				Three Months Ended				Six Months Ended				Six Months Ended
		August 31, 2024				August 31, 2023				August 31, 2024				August 31, 2023
Device rental activities		$	1,065,898			$	343,543			$	2,046,434			$	581,692
Direct sales of goods and services			278,285				42,820				480,549				189,879
		$	1,344,183			$	386,363			$	2,526,983			$	771,571

 

- 14 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

5. LEASES

 

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

 

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

 

Below is a summary of our lease assets and liabilities at August 31, 2024 and February 29, 2024.

 

Leases		Classification		August 31, 2024				February 29, 2024
Assets
Operating		Operating Lease Assets		$	1,070,511			$	1,139,188
Liabilities
Current
Operating		Current Operating Lease Liability		$	225,348			$	237,653
Noncurrent
Operating		Noncurrent Operating Lease Liabilities			837,844				889,360
Total lease liabilities				$	1,063,192			$	1,127,013

 

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

 

Rent expense and operating lease cost was $62,967 and $124,980 for the three and six months ended August 31, 2024, respectively, and $62,541 and $125,083 for the three and six months ended August 31, 2023, respectively.

 

6. REVENUE EARNING DEVICES

 

Revenue earning devices consisted of the following:

 

		August 31, 2024				February 29, 2024
Revenue earning devices		$	5,163,379			$	3,432,846
Less: Accumulated depreciation			(1,513,990	)			(952,844	)
		$	3,649,389			$	2,480,002

 

During the three and six months ended August 31, 2024 the Company made total additions to revenue earning devices of $602,358 and $1,730,533, respectively, which were transfers from inventory. During the three and six months ended August 31, 2023 the Company made total additions to revenue earning devices of $341,042 and $785,464, respectively, which were transfers from inventory.

 

Depreciation and Amortization		Three Months Ended August 31, 2024				Three Months Ended August 31 2023				Six Months Ended August 31, 2024				Six Months Ended August 31 2023
Cost of Goods Sold		$	240,000			$	111,575			$	441,873			$	208,539
Operating expenses			64,918				30,039				119,273				55,916
Total Depreciation and Amortization		$	304,918			$	141,614			$	561,146			$	264,455

 

- 15 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

7. FIXED ASSETS

 

Fixed assets consisted of the following:

 

		August 31, 2024				February 29, 2024
Automobile		$	74,237			$	74,237
Demo devices			244,900				194,352
Tooling			107,020				107,020
Machinery and equipment			8,825				8,825
Computer equipment			157,446				150,387
Office equipment			15,312				15,312
Furniture and fixtures			21,225				21,225
Warehouse equipment			36,305				19,639
Leasehold improvements			26,956				26,956
			692,226				617,953
Less: Accumulated depreciation			(434,043	)			(349,878	)
		$	258,183			$	268,075

 

During the three months ended August 31, 2024, the Company made additions of $22,097 of which $17,505 were transfers from inventory with remaining additions of $4,592. During the six months ended August 31, 2024, the Company made additions of $74,274 of which $50,550 were transfers from inventory with remaining additions of $23,724. During the three months ended August 31, 2023, the Company made additions of $75,057 which were transfers from inventory. During the six months ended August 31, 2023, the Company made additions of $107,230 of which $103,767 were transfers from inventory with remaining additions of $3,463.

 

Depreciation expense was $42,844 and $84,165 for the three and six months ended August 31, 2024, respectively, and $49,427 and $94,528 for the three and six months ended August 31, 2023, respectively.

 

8. DEFERRED VARIABLE PAYMENT OBLIGATION

 

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

 

On May 9, 2019 the Company entered into two similar arrangements with two investors:

 

	(1)	The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
	(2)	The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

 

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

 

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

 

- 16 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

 

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

 

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

 

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

 

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

 

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.

 

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of August 31, 2024, the Company has accrued $1,315,264 in Payments of which $667,633 are in arrears. As of February 29, 2024, the Company has accrued approximately $904,377 in Payments, of which $542,176 is in arrears. No notices have been sent to the Company.

 

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

 

	1)	The rate payment was reduced from 14.25 % to 9.65 %
	2)	The asset disposition % (see below) was reduced from 31 % to 21%

 

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

 

- 17 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of August 31, 2024, and February 29, 2024, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

 

For both the three months and six months ended August 31, 2023 and year ended February 28, 2023, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both August 31, 2024 and February 29, 2024.

 

9. RELATED PARTY TRANSACTIONS

 

For both the three months ended August 31, 2024 and August 31, 2023 , the Company had no repayments of net advances from its loan payable-related party At August 31, 2024 the loan payable-related party was $279,589 and $257,438 at February 29, 2024. Included in the balance due to the related party at August 31, 2024 is $203,057 of deferred salary and interest, $152,513 of which bears interest at 12%. As of February 29, 2024, included in the balance due to the related party is $140,013 of deferred salary all of which bears interest at 12%. The accrued interest included in loan at August 31, 2024 and February 29, 2024 was $41,549 and $32,468, respectively.

 

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended August 31, 2023, the Company accrued $0 (2023-$62,000) and $0 (2023-$125,000) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At August 31, 2024 and February 29, 2024 there was $2,500,000 and $2,500,000 of incentive compensation payable. 

 

At August 31, 2024 deferred compensation for CEO was $204,091. For the 6 months ended August 31, 2024,the net change was a decrease of $334,676 comprising of cash repayment of $505,000 offset by accruals and adjustments of $170,324. At February 29, 2024 deferred compensation for CEO was $538,767.

 

During the three months ended August 31, 2024 and 2023, the Company was charged $777,260 and $777,260, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

During the six months ended August 31, 2024 and 2023, the Company was charged $1,289,830 and $1,659,275, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

10. OTHER DEBT – VEHICLE LOAN

 

In December 2016, RAD entered into a vehicle loan for $47,704 secured by the vehicle. The loan is repayable over 5 years maturing November 9, 2021, and repayable $1,019 per month including interest and principal. In November 2017, RAD entered into another vehicle loan secured by the vehicle for $47,661. The loan is repayable over 5 years, maturing October 24, 2022 and repayable at $923 per month including interest and principal. The principal repayments made were $0 for both the year ended February 28, 2022 and February 28, 2021. Regarding the second vehicle loan, the vehicle was returned at the end of fiscal 2019 and the car was subsequently sold by the lender for proceeds of $21,907 which went to reduce the outstanding balance of the loan. A loss of $3,257 was recorded as well. A balance of $21,578 remains on this vehicle loan at both February 28, 2021 and February 29, 2020. For the first vehicle loan, the vehicle was retired in 2020, the proceeds of the disposal of $18,766 was applied against the balance of the loan with a $5,515 gain on the remaining asset value of $13,251. A balance of $16,944 remains on this vehicle loan at both February 28, 2022 and February 28, 2021. The remaining total balances of the amounts owed on the vehicle loans were $38,522 and $38,522 as of August 31, 2024 and February 29, 2024, respectively, of which all were classified as current.

 

- 18 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

11. LOANS PAYABLE

 

Loans payable at August 31, 2024 consisted of the following:

  

												Annual
Date		Maturity		Description				Principal				Interest Rate
July 18, 2016		July 18, 2017		Promissory note		(1)*		$	3,500				22	%
December 10, 2020		March 1, 2025		Promissory note		(2)			3,921,168				12	%
December 10, 2020		March 1, 2025		Promissory note		(3)			2,754,338				12	%
December 10, 2020		December 10, 2024		Promissory note		(4)			165,605				12	%
December 14, 2020		March 1, 2027		Promissory note		(5)			310,375				12	%
December 30, 2020		March 1, 2025		Promissory note		(6)			350,000				12	%
January 1, 2021		March 1, 2025		Promissory note		(7)			25,000				12	%
January 1, 2021		March 1, 2025		Promissory note		(8)			145,000				12	%
January 14, 2021		March 1, 2025		Promissory note		(9)			550,000				12	%
February 22, 2021		March 1, 2025		Promissory note		(10)			1,650,000				12	%
March 1, 2021		March 1, 2025		Promissory note		(11)			6,000,000				12	%
June 8, 2021		June 8, 2025		Promissory note		(12)			2,750,000				12	%
July 12, 2021		July 26, 2026		Promissory note		(13)			3,740,360				7	%
September 14, 2021		September 14, 2025		Promissory note		(14)			1,650,000				12	%
July 28, 2022		March 1, 2025		Promissory note		(15)			170,000				15	%
August 30, 2022		August 30,2025		Promissory note		(16)			3,000,000				15	%
September 7, 2022		March 1, 2025		Promissory note		(17)			400,000				15	%
September 8, 2022		March 1, 2025		Promissory note		(18)			475,000				15	%
October 13, 2022		March 1, 2025		Promissory note		(19)			350,000				15	%
October 28, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
November 9, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
November 10, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
November 15, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
January 11, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
February 6, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
April 5. 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
April 20, 23		October 31, 2026		Promissory note		(20)			400,000				15	%
May 11, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
October 27, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
November 30, 2023		April 30, 2025		Purchase Agreement		(21)			203,000				35	%
March 8, 2024		August 8, 2025		Purchase Agreement		(22)			350,000				35	%
August 8, 2024		August 8, 2025		Exchange Agreement		(23)			200,000				12	%
								$	33,163,346
Less: current portion of loans payable									(23,462,611	)
Less: discount on non-current loans payable									(413,071	)
Non-current loans payable, net of discount								$	9,287,664
Current portion of loans payable								$	23,462,611
Less: discount on current portion of loans payable									(88,993	)
Current portion of loans payable, net of discount								$	23,373,618

 

*	In default

 

- 19 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

On March 1, 2024 the Company adjusted the relative fair value unamortized discount on the above notes by $4,175,535 with a corresponding adjustment to accumulated deficit to apply ASU 2020-06.

 

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
(4)	This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.
(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.
(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $2,439 and $3,954, respectively, with an unamortized discount of $4,445 at August 31, 2024.
(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.
(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.

 

- 20 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $3,117 and $5,053, respectively, with an unamortized discount of $5,506 at August 31, 2024.
(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $16,759 and $26,243, respectively, with an unamortized discount of $29,342 at August 31, 2024.
(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025.
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $1,239 and $1,339, respectively, with an unamortized discount of $2,782 at August 31, 2024.
(13)	This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2024 there were repayments of $9,000 and $36,000 , respectively on the note.

 

- 21 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $14,301 and $19,928, respectively, with an unamortized discount of $46,918 at August 31, 2024. This note was extended to September 14, 2025.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
(20)	On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
	October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,455 and $7,065, respectively, with an unamortized discount of $40,827 at August 31, 2024.

 

- 22 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(20)

November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,294 and $7,097, respectively, with an unamortized discount of $41,029 at August 31, 2024.

 

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,238 and $7,119, respectively, with an unamortized discount of $41,171 at August 31, 2024.

 

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,262 and $7,076, respectively, with an unamortized discount of $40,900 at August 31, 2024.

 

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,266 and $7,096, respectively, with an unamortized discount of $41,028 at August 31, 2024.

 

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,314 and $7,130, respectively, with an unamortized discount of $41,174 at August 31, 2024.

 

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,305 and $7,135, respectively, with an unamortized discount of $41,274 at August 31, 2024.

 

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,484 and $7,186, respectively, with an unamortized discount of $41,591 at August 31, 2024.

 

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $7,269 and $7,350, respectively, with an unamortized discount of $42,628 at August 31, 2024.

 

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $5,876 and $7,163, respectively, with an unamortized discount of $41,448 at August 31, 2024.

 

- 23 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(21)	On November 30, 2023, the Company entered into an agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent.
(22)	On March 8, 2024, the Company entered into another agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent.
(23)	On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at August 31, 2024 is $200,000.

 

12. STOCKHOLDERS’ EQUITY (DEFICIT)

 

Summary or Preferred Stock Activity

 

Series B Convertible, Redeemable Preferred Stock (Temporary Equity)

 

On April 27, 2024, in connection with a Share Purchase Agreement the Company created a new class Of Series B Convertible Redeemable Preferred Shares with 5,000 authorized shares. The Company received gross proceeds of $300,000 with net proceeds of $278,000 less $10,000 in legal fees and 12,000 in broker fees both charged against paid in capital. In addition, as a commitment fee the Company issued an additional 20 Series B Convertible Redeemable Preferred Shares, with a fair value of $24,000 charged to paid in capital. The shares have a redemption value of $1,200 per share. The Company must redeem one third of these shares in 30, days and each 30 days thereafter until all the shares are redeemed at 90 days. The Company must also pay an 8% dividend from issue date to redemption date. On May 30, June 28 and July 28, 2024 the Company then issued total dividends of 4.32 shares of Series B Convertible Redeemable Preferred Shares having a value of $5,188 and fully redeemed the outstanding 324 Series B shares for $389,189 including deemed dividends of $89,189 which represents the redemption value over the purchase cost of the shares.

 

At August 31, 2024 there are 0 Series B Convertible Redeemable Preferred Shares outstanding.

 

Series F Convertible Preferred Shares

 

During the six months ended August 31, 2024, a Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 12). The Company record an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.

 

Summary of Preferred Stock Warrant Activity

 

		Number of Series F Preferred Warrants				Weighted Average Exercise Price				Weighted Average Remaining Years
Outstanding at March 1, 2023			939			$	1.00				9.50
Issued			—				—				—
Exercised			—				—				—
Forfeited and cancelled			—				—				—
Outstanding at August 31, 2024			939			$	1.00				9.20

 

 

- 24 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Summary of Common Stock Activity

 

The Company increased authorized common shares from 12,500,000,000 to 15,000,000,000 on October 4, 2024.

 

For the three months ended August 31, 2024, the Company issued 1,330,610,802 common shares with gross proceeds of $4,687,016 and net proceeds of $4,491,360 after issuance costs of $195,656. For the six months ended August 31, 2024, the Company issued 2,410,777,227 common shares with gross proceeds of $7,485,654 and net proceeds of $7,173,953 after issuance costs of $311,701. In addition, for the three and six months ended the Company issued 57,142,857 issuable shares as payment for $200,000 pf principle on a note payable. (see Note 12)

 

The table below represent the common shares issued, issuable and outstanding at August 31, 2024 and February 29, 2024:

 

Common shares		August 31, 2024				February 29, 2024
Issued			11,649,528,185				9,238,750,958
Issuable			57,142,857				—
Issued, issuable and outstanding			11,706,671,042				9,238,750,958

 

Summary of Common Stock Warrant Activity

 

For the three months and six months ended August 31, 2024 and August 31, 2023, the Company recorded a total of $83,323 and $50,713, and $166,646 and $103,434 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

 

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Years
Outstanding at March 1, 2024			300,595,661			$	0.003				1.00
Issued			—				—				—
Exercised			—				—				—
Forfeited and cancelled			—				—				—
Outstanding at August 31, 2024			300,595,661			$	0.003				0.49

 

Summary of Common Stock Option Activity -Employee Stock Options

 

		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Years
Outstanding at March 1, 2024			188,667,035			$	0.02				4.10
Issued			—				—				—
Exercised			—				—				—
Forfeited, extinguished and cancelled			(3,011,029	)		$	0.02				(4.60	)
Outstanding at August 31, 2024			185,656,006			$	0.02				4.00

 

- 25 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

13. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

The related legal costs are expensed as incurred.

 

Operating Lease

 

On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

 

On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.

 

On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month. The Company paid a security deposit of $1,500.

 

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

 

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $62,967 and $124,980 for the three and six months ended August 31, 2024, respectively, and 62,541 and $125,083 for the three and six months ended August 31, 2023, respectively.

 

Maturity of Lease Liabilities		Operating Leases
August 31, 2025		$	225,348
August 31, 2026			225,348
August 31, 2027			214,970
August 31, 2028			207,558
August 31, 2029			207,558
August 31, 2030 and after			345,930
Total lease payments			1,426,712
Less: Interest			(363,520	)
Present value of lease liabilities		$	1,063,192

 

- 26 -

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

14. EARNINGS (LOSS) PER SHARE

 

The net income (loss) per common share amounts were determined as follows:

 

		For the Three Months Ended								For the Six Months Ended
		August 31,								August 31,
		2024				2023				2024				2023
Numerator:
Net loss		$	(3,930,323	)		$	(4,759,728	)		$	(8,124,682	)		$	(9,314,919	)
Deduct : Dividend on Series B shares			(60,833	)			—				(89,689	)			—
Deduct: Deemed dividend on redemption of Series F shares			(334,187	)			—				(334,187	)			—
Net loss available to common shareholders			(4,325,343	)			(4,759,728	)			(8,548,558	)			(9,314,919	)
Denominator:
Weighted average shares – basic			11,181,863,976				6,568,957,612				10,531,991,040				6,266,833,467
Net income (loss) per share – basic		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Dilutive effect of common stock equivalents:
Convertible notes and accrued interest			—				—				—				—
Convertible Series F Preferred Shares			—				—				—				—
Stock options and warrants			—				—				—				—
			—				—				—				—
Denominator:
Weighted average shares – diluted			11,181,863,976				6,568,957,612				10,531,991,040				6,266,833,467
Net income (loss) per share – diluted		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)

 

The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2024 and 2032 were as follows:

 

		For the Three Months Ended								For the Six Months Ended
		August 31,								August 31,
		2024				2023				2024				2023
Convertible notes and accrued interest			—				—				—				—
Convertible Series F Preferred Shares			40,388,015,095				24,286,988,436				40,388,015,095				24,286,988,436
Stock options and warrants			486,251,667				433,767,451				486,251,667				433,767,451
Total			40,874,266,762				24,720,755,887				40,874,266,762				24,720,755,887

 

15. SUBSEQUENT EVENTS

 

Subsequent to August 31, 2024:

 

— The Company issued 335,000,000 common shares pursuant to a share purchase agreement for gross proceeds of $850,551, issuance costs of $37,097 and net proceeds of $813,454.

 

— The Board of Directors approved to increase authorized common shares from 12,500,000,000 to 15,000,000,000 on October 4, 2024.

 

— On September 24, 2024 a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet entered into on June 7, 2024. The Company and its counsel believe the claim is without merit and will contest it vigorously. Accordingly, the Company has made no accruals.

 

- 27 -

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The following discussion of our financial condition and results of operations for the three and six months ended August 31, 2024 and August 31, 2023 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 29, 2024, as filed on May 29, 2024 with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

Unless expressly indicated or the context requires otherwise, the terms “AITX”, the “Company”, “we”, “us”, and “our” refer to Artificial Intelligence Technology Solutions Inc.

 

Overview

 

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX’s fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

 

AITX’s mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

 

A short list of basic examples include:

 

	1.	Typical security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario applies to perimeters, interior yard areas, and related similar environments.
	2.	Integrated hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.
	3.	Automation of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions in use today.

 

RAD solutions are unique because they:

 

	1.	Start with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for a manned response, as needed.
	2.	Use unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new functionality.
	3.	Deliver services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of maintenance of complex video and security platforms.

 

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

 

- 28 -

Table of Contents

 

Management Discussion and Analysis

 

Results of Operations for the Three Months Ended August 31, 2024 and 2023

 

The following table shows our results of operations for the three months ended August 31, 2024 and 2023. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

 

		Period
		Three Months Ended				Three Months Ended				Change
		August 31, 2024				August 31, 2023				Dollars				Percentage
Revenues		$	1,344,183			$	386,363			$	957,820				248	%
Gross profit			559,218				185,774				373,444				201	%
Operating expenses			3,173,092				3,231,026				(57,934	)			(2	)%
Loss from operations			(2,613,874	)			(3,045,252	)			431,378				14	%
Other income (expense), net			(1,316,449	)			(1,714,476	)			398,027				23	%
Net Loss		$	(3,930,323	)		$	(4,759,728	)		$	829,405				17	%

 

Revenue

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

		Three Months Ended				Three Months Ended				Change
		August 31, 2024				August 31, 2023				Dollars				Percentage
Device rental activities		$	1,065,898			$	343,543			$	722,355				210	%
Direct sales of goods and services			278,285				42,820				235,465				550	%
		$	1,344,183			$	386,363			$	957,820				248	%

 

Total revenue for the three-month period ended August 31, 2024 was $1,344,183 which represented an increase of $957,820 compared to total revenue of $386,363 for the three months ended August 31, 2023. Rental activities increased by 210% over the prior year’s quarter and direct sales by $235,465 as the Company continues to grow its core business.

 

Gross profit

 

Total gross profit for the three-month period ended August 31, 2024 was $559,218, which represented an increase of $373,444 compared to gross profit of $185,774 for the three months ended August 31, 2023. The gross profit increased due to the higher sales. The gross profit % of 42% for the three-month period ended August 31, 2024 was lower than the gross profit % of 48% for the prior year’s corresponding period.

 

Operating Expenses

 

		Period
		Three Months Ended				Three Months Ended				Change
		August 31, 2024				August 31, 2023				Dollars				Percentage
Research and development		$	677,410			$	794,548			$	(117,138	)			(15	)%
General and administrative			2,324,953				2,294,471				30,482				1	%
Depreciation and amortization			107,762				79,466				28,296				36	%
Operating lease cost and rent			62,967				62,541				426				1	%
Operating expenses		$	3,173,092			$	3,231,026			$	(57,934	)			(2	)%

 

- 29 -

Table of Contents

 

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended August 31, 2024 and August 31, 2023, were $3,173,092 and $3,231,026, respectively. The overall decrease of $57,934 was primarily attributable to the following changes in operating expenses of:

 

	●	General and administrative expenses increased by $30,482. In comparing the three months ended August 31, 2024 and August 31, 2023 the increase in G&A was primarily due to increases in wages and salaries of $348,837 and subcontractors of $46,581. These increases were partially offset by decreases in: professional fees of $170,274, stock-based compensation of $58,984, production supplies of $19,712, marketing of $19,712, freight of $4,362 and travel of $79,408
	●	Research and development decreased by $117,138 due to a reduction in funding on development of future products.
	●	Depreciation and amortization increased by $28,926 due to increases in revenue earning devices, demo devices, warehouse equipment and computer equipment.
	●	Operating lease cost and rent increased by $426.

 

Other Income (Expense)

 

Other income (expense) consisted of interest. Other income (expense) during the three months ended August 31, 2024 and August 31, 2023, was ($1,316,449) and ($1,714,476), respectively. The $398,027 decrease in other expense was primarily attributable to the application of ASU-2020 06 in the current year which resulted in lower amortization expense.

 

Net loss

 

We had a net loss of $3,930,323 for the three months ended August 31, 2024, compared to a net loss of $4,759,728 for the three months ended August 31, 2023. The decrease in net loss of $829,405 is primarily a result of higher gross profit and lower other expense.

 

Results of Operations for the Six Months Ended August 31, 2024 and 2023

 

The following table shows our results of operations for the six months ended August 31, 2024 and 2023. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

 

Revenue

 

		Period
		Six Months Ended				Six Months Ended				Change
		August 31, 2024				August 31, 2023				Dollars				Percentage
Revenues		$	2,526,983			$	771,571			$	1,755,412				228	%
Gross profit			1,244,552				382,507				862,045				225	%
Operating expenses			6,691,682				6,376,734				314,948				5	%
Loss from operations			(5,447,130	)			(5,994,227	)			547,097				9	%
Other income (expense), net			(2,677,552	)			(3,320,692	)			643,140				19	%
Net loss		$	(8,124,682	)		$	(9,314,919	)		$	1,190,237				13	%

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

		Six Months Ended				Six Months Ended				Change
		August 31, 2024				August 31, 2023				Dollars				Percentage
Device rental activities		$	2,046,434			$	581,692			$	1,464,742				252	%
Direct sales of goods and services			480,549				189,879				290,670				153	%
		$	2,526,983			$	771,571			$	1,755,412				228	%

 

- 30 -

Table of Contents

 

Total revenue for the six-month period ended August 31, 2024 was $2,526,983 which represented an increase of $1,755,412 compared to total revenue of $771,571 for the six months ended August 31, 2023. This increase is a result of an increase in rental sales of $1,464,742 as the Company deployed more units as well as an increase in direct sales of $290,670.

 

Gross profit

 

Total gross profit for the six-month period ended August 31, 2024 was $1,244,552 which represented an increase of $862,045, compared to gross profit of $382,507 for the six months ended August 31, 2023. The gross profit increased due to the higher sales. The gross profit % was 49% for both the six month period ended August 31, 2024 and 2023.

 

Operating Expenses

 

		Period
		Six Months Ended				Six Months Ended				Change
		August 31, 2024				August 31, 2023				Dollars				Percentage
Research and development		$	1,318,120			$	1,686,305			$	(368,185	)			(22	)%
General and administrative			5,045,144				4,414,902				630,932				14	%
Depreciation and amortization			203,438				150,444				52,994				35	%
Operating lease cost and rent			124,980				125,083				(103	)			0	%
Operating expenses		$	6,691,682			$	6,376,734			$	314,948				5	%

 

General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the six-month period ended August 31, 2024 and August 31, 2023, were $6,691,682 and $6,376,734, respectively. The overall increase of $314,948 was primarily attributable to the following changes in operating expenses of:

 

	●	General and administrative expenses increased by $630,932. In comparing the six months ended August 31, 2024 and August 31, 2023 the increase may be partially explained by the following decreases: wages and salaries by $478,383, subcontractors by $94,505, professional fees by $173,272, commissions by $110,694. freight by $121,524, installation costs by$85,403, and RMC costs by $164,710. These were partially offset by decreases in the following accounts: professional fees by $144,064, stock-based compensation by $91,382, travel by $66,762, repairs and maintenance by $66,478, sales and marketing by $41,630, production supplies by $38,244 and other general and administrative decreases.
	●	Research and development decreased by $368,185 due to a reduction in funding on development of future products.
	●	Depreciation and amortization increased by $52,994 due to the acquisition of revenue earning devices, demo devices, warehouse equipment and computer equipment.
	●	Operating lease cost and rent decreased by $103.

 

Other Income (Expense)

 

Other income (expense) during the six months ended August 31, 2024 and August 31, 2023, was ($2,677,552) and ($3,320,692), respectively. The $643,140 decrease in other expense was primarily attributable to the application of ASU-2020 06 in the current year which resulted in lower amortization expense.

 

Net loss

 

We had a net loss of $8,124,682 for the six months ended August 31, 2024, compared to a net loss of $9,314,919 for the six months ended August 31, 2023. The decrease in net loss of $1,190,237 is a result of higher gross profit and a reduction on other expense.

 

- 31 -

Table of Contents

 

Liquidity, Capital Resources and Cash Flows

 

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

 

As of August 31, 2024, we had a cash balance of $543,133, accounts receivable of $650,293, device parts inventory of $2,063,229 and $37,080,711in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

 

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

 

Capital Resources

 

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

 

		May 31, 2024				February 29, 2024
Current assets		$	4,090,105			$	3,616,566
Current liabilities			37,080,711				21,715,651
Working capital		$	(32,990,606	)		$	(18,099,085	)

 

As of August 31, 2024 and February 29, 2024, we had a cash balance of $543,133 and $105,926, respectively.

 

Summary of Cash Flows

 

Summary of Cash Flows		Six Months Ended August 31, 2024				Six Months Ended August 31, 2023
Net cash used in operating activities		$	(6,433,906	)		$	(6,335,216	)
Net cash used in investing activities		$	(77,868	)		$	(3,463	)
Net cash provided by financing activities		$	6,948,981			$	6,911,032

 

Net cash used in operating activities.

 

Net cash used in operating activities for the six months ended August 31, 2024 was $6,433,906 which included a net loss of $8,124,682 non-cash activity such as the bad debts expense of $11,995, inventory provision of $111,000, reduction of right of use asset of $63,821, accretion of lease liability $61,159, stock based compensation of $166,646, loss on settlement of debt of $6,520, change in operating assets and liabilities of $472,840, amortization of debt discount of $129,333, increase in related party accrued payroll and interest of $22,151 and depreciation and amortization of $645,311 to derive the uses of cash in operations.

 

Net cash used in investing activities.

 

Net cash used in investing activities for the six months ended August 31, 2024 was $77,868, $23,724 for the purchase of fixed assets, $4,144 for acquisition of trademarks and $50,000 for a convertible note receivable.

 

Net cash provided by financing activities.

 

Net cash provided by financing activities was $6,948,981 for the six months ended August 31, 2024. This consisted of share proceeds net of issuance costs of 6,893,169, proceeds from loans payable of $350,000, reduced by repayments on loans payable of $183,000, proceeds on the issuance of Series B redeemable convertible preferred shares of $278,000 reduced by redemption of those same Series B redeemable convertible preferred shares of $389,188.

 

Off-Balance Sheet Arrangements

 

None.

 

- 32 -

Table of Contents

 

Critical Accounting Policies and Estimates

 

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 29, 2024, as filed on May 29, 2024.

 

Related Party Transactions

 

For both the three months ended August 31, 2024 and August 31, 2023 , the Company had no repayments of net advances from its loan payable-related party At August 31, 2024 the loan payable-related party was $279,589 and $257,438 at February 29, 2024. Included in the balance due to the related party at August 31, 2024 is $203,057 of deferred salary and interest, $152,513 of which bears interest at 12%. As of February 29, 2024, included in the balance due to the related party is $140,013 of deferred salary all of which bears interest at 12%. The accrued interest included in loan at August 31, 2024 and February 29, 2024 was $41,549 and $32,468, respectively.

 

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended August 31, 2023, the Company accrued $0 (2023-$62,000) and $0 (2023-$125,000) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At August 31, 2024 and February 29, 2024 there was $2,500,000 and $2,500,000 of incentive compensation payable. 

 

At August 31, 2024 deferred compensation for CEO was $204,091. For the 6 months ended August 31, 2024,the net change was a decrease of $334,676 comprising of cash repayment of $505,000 offset by accruals and adjustments of $170,324. At February 29, 2024 deferred compensation for CEO was $538,767.

 

During the three months ended August 31, 2024 and 2023, the Company was charged $777,260 and $777,260, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

During the six months ended August 31, 2024 and 2023, the Company was charged $1,289,830 and $1,659,275, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable for a smaller reporting company.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Report on Internal Control over Financial Reporting

 

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of August 31, 2024. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of August 31, 2024, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

	1.	As of August 31, 2024, we did not maintain effective controls over our control environment. Specifically, we have not developed and effectively communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.
	2.	As of August 31, 2024, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.

 

Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

- 33 -

Table of Contents

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

This item is not applicable to smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Each issuance of securities was issued without registration in reliance of the exemption from registration Section 3(a)9 of the Securities Act of 1933.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

The Company has not defaulted upon senior securities.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable to the Company.

 

ITEM 5. OTHER INFORMATION

 

None.

 

- 34 -

Table of Contents

 

ITEM 6. EXHIBITS

 

Exhibit No.		Description of Document
3.1		Articles of Incorporation (1)
3.2		Bylaws (2)
14		Code of Ethics (2)
21		Subsidiaries of the Registrant (3)
31.1		Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer. (3)
31.2		Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial and accounting officer. (3)
32.1		Section 1350 Certification of principal executive officer. (3)
32.2		Section 1350 Certification of principal financial accounting officer. (3)
101.INS		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3)
101.SCH		Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) (3)

 

 

(1)	Incorporated by reference to our Form 10-KT file with the Securities and Exchange Commission on March 12, 2018.
(2)	Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on August 4, 2010.
(3)	Filed or furnished herewith.

 

- 35 -

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	Artificial Intelligence Technology Solutions Inc.
Date: October 15, 2024	BY:	/s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)
Date: October 15, 2024	BY:	/s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

 

- 36 -

 

 

Exhibit 21.1

 

Artificial Intelligence Technology Solutions Inc.

 

Subsidiaries

 

Name		Jurisdiction of Incorporation
Robotic Assistance Devices, Inc.		Nevada
Robotic Assistance Devices Group, Inc.		Nevada
Robotic Assistance Devices Mobile, Inc.		Nevada

 

 

Exhibit 31.1

 

RULE 13A-14(A)/15D-14(A) CERTIFICATION

 

I, Steven Reinharz, certify that:

 

1. I have reviewed this Form 10-Q for the period ended August 31, 2024 of Artificial Intelligence Technology Solutions Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: October 15, 2024	BY:	/s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)

 

 

 

Exhibit 31.2

 

RULE 13A-14(A)/15D-14(A) CERTIFICATION

 

I, Anthony Brenz, certify that:

 

1. I have reviewed this Form 10-Q for the period ended August 31, 2024 of Artificial Intelligence Technology Solutions Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: October 15, 2024	BY:	/s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

 

 

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

 

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the “Company”) on Form 10-Q for the period ended August 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Steven Reinharz, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: October 15, 2024	BY:	/s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

Exhibit 32.2

 

SECTION 1350 CERTIFICATION

 

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the “Company”) on Form 10-Q for the period ended August 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Anthony Brenz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: October 15, 2024	BY:	/s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

Cover - shares	6 Months Ended
	Aug. 31, 2024	Sep. 30, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Aug. 31, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--02-28
Entity File Number	000-55079
Entity Registrant Name	ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
Entity Central Index Key	0001498148
Entity Tax Identification Number	27-2343603
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10800 Galaxie Avenue
Entity Address, City or Town	Ferndale
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48220
City Area Code	(877)
Local Phone Number	787-6268
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,911,671,042

Condensed Consolidated Balance Sheets - USD ($)	Aug. 31, 2024	Feb. 29, 2024	[1]
Current assets:
Cash	$ 543,133	$ 105,926
Accounts receivable, net	650,293	756,084
Share proceeds receivable	280,783
Device parts inventory, net	2,063,229	2,131,599
Prepaid expenses and deposits	552,667	622,957
Total current assets	4,090,105	3,616,566
Operating lease asset	1,070,511	1,139,188
Revenue earning devices, net of accumulated depreciation of $1,513,990 and $952,844, respectively	3,649,389	2,480,002
Fixed assets, net of accumulated depreciation of $434,043 and $349,878, respectively	258,183	268,075
Trademarks	31,224	27,080
Convertible note receivable	50,000
Investment at cost	50,000	50,000
Security deposit	15,880	15,880
Total assets	9,215,292	7,596,791
Current liabilities:
Accounts payable and accrued expenses	1,882,487	2,032,707
Advances payable- related party	1,594	1,594
Customer deposits	363,572	73,702
Current operating lease liability	225,348	237,653
Current portion of deferred variable payment obligation	1,315,264	904,377
Loan payable - related party	279,589	257,438
Deferred compensation for CEO	204,091	538,767
Current portion of loans payable, net of discount of $88,993 and $688,598	23,373,618	13,190,882
Vehicle loan - current portion	38,522	38,522
Current portion of accrued interest payable	9,396,626	4,440,009
Total current liabilities	37,080,711	21,715,651
Non-current operating lease liability	837,844	889,360
Loans payable, net of discount of $413,071 and $4,118,332, respectively	9,287,664	14,798,532
Deferred variable payment obligation	2,525,000	2,525,000
Incentive compensation plan payable	2,500,000	2,500,000
Accrued interest payable	2,454,436	5,367,805
Total liabilities	54,685,655	47,796,348
Commitments and Contingencies
Redeemable Preferred Stock (Temporary Equity):
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly, $1,200 stated value, 5,000 shares authorized, 0 and 0 shares issued and outstanding at August 31, 2024 and February 29, 2024, respectively
Stockholders’ deficit:
Preferred Stock, value
Common Stock, $0.00001 par value; 15,000,000,000 shares authorized 11,706,671,042 and 9,238,750,958 shares issued, issuable and outstanding, respectively	117,067	92,388
Additional paid-in capital	99,993,641	92,565,513
Preferred stock to be issued	99,086	99,086
Accumulated deficit	(145,686,020)	(132,962,427)
Total stockholders’ deficit	(45,470,363)	(40,199,557)
Total liabilities and stockholders’ deficit	9,215,292	7,596,791
Series G Preferred Stock [Member]
Stockholders’ deficit:
Preferred Stock, value
Series E Preferred Stock [Member]
Stockholders’ deficit:
Preferred Stock, value	3,350	3,350
Series F Preferred Stock [Member]
Stockholders’ deficit:
Preferred Stock, value	$ 2,513	$ 2,533
[1] Derived from audited information

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Aug. 31, 2024	Feb. 29, 2024
Accumulated depreciation, revenue earning devices	$ 1,513,990	$ 952,844
Accumulated depreciation, fixed assets	434,043	349,878
Discount of current portion of loans payable	88,993	688,598
Discount of loans payable	$ 413,071	$ 4,118,332
Preferred stock, shares authorized	15,535,000	15,535,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	15,000,000,000	15,000,000,000
Common stock, shares issued	11,706,671,042	9,238,750,958
Common stock, shares outstanding	11,706,671,042	9,238,750,958
Redeemable Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Cumulative dividend payable, percentage	8.00%	8.00%
Cumulative dividend payable, stated value	$ 1,200	$ 1,200
Temporary equity, shares authorized	5,000	5,000
Temporary equity, shares issued	0	0
Temporary equity, shares outstanding	0	0
Series G Preferred Stock [Member]
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, par value	$ 0.001	$ 0.001
Series E Preferred Stock [Member]
Preferred stock, shares authorized	4,350,000	4,350,000
Preferred stock, shares issued	3,350,000	3,350,000
Preferred stock, shares outstanding	3,350,000	3,350,000
Preferred stock, par value	$ 0.001	$ 0.001
Series F Preferred Stock [Member]
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	2,513	2,533
Preferred stock, shares outstanding	2,513	2,533
Preferred stock, par value	$ 1.00	$ 1.00

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Revenues	$ 1,344,183	$ 386,363	$ 2,526,983	$ 771,571
Cost of Goods Sold	784,965	200,589	1,282,431	389,064
Gross Profit	559,218	185,774	1,244,552	382,507
Operating expenses:
Research and development (Note 9)	677,410	794,548	1,318,120	1,686,305
General and administrative	2,324,953	2,294,471	5,045,144	4,414,902
Depreciation and amortization	107,762	79,466	203,438	150,444
Operating lease cost and rent	62,967	62,541	124,980	125,083
Total operating expenses	3,173,092	3,231,026	6,691,682	6,376,734
Loss from operations	(2,613,874)	(3,045,252)	(5,447,130)	(5,994,227)
Other income (expense), net:
Interest expense	(1,309,929)	(1,753,216)	(2,671,032)	(3,359,432)
Gain (loss) on settlement of debt	(6,520)	38,740	(6,520)	38,740
Total other expense net	(1,316,449)	(1,714,476)	(2,677,552)	(3,320,692)
Net loss	$ (3,930,323)	$ (4,759,728)	$ (8,124,682)	$ (9,314,919)
Net loss per share - basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Net loss per share - diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common share outstanding - basic	11,181,863,976	6,568,957,612	10,531,991,040	6,266,833,467
Weighted average common share outstanding - diluted	11,181,863,976	6,568,957,612	10,531,991,040	6,266,833,467
Purchases And Overhead [Member]
Cost of Goods Sold	$ 544,965	$ 89,014	$ 840,558	$ 180,525
Depreciation And Amortization [Member]
Cost of Goods Sold	$ 240,000	$ 111,575	$ 441,873	$ 208,539

Condensed Consolidated Statement of Shareholders' Deficit (Unaudited) - USD ($)	Temporary Equity [Member] Series B Preferred Stock [Member]	Preferred Stock [Member] Series E Preferred Stock [Member]	Preferred Stock [Member] Series F Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Feb. 28, 2023		$ 3,350	$ 101,619	$ 58,489	$ 80,247,252	$ (112,253,711)	$ (31,843,001)
Beginning balance, shares at Feb. 28, 2023		3,350,000	2,533	5,848,741,599
Issuance of shares, net of issuance costs				$ 2,809	1,316,100		1,318,909
Issuance of shares, net of issuance costs, shares				280,929,190
Relative fair value of Series F warrants issued with debt					947,447		947,447
Stock based compensation					52,721		52,721
Net income						(4,555,193)	(4,555,193)
Ending balance, value at May. 31, 2023		$ 3,350	$ 101,619	$ 61,298	82,563,520	(116,808,904)	(34,079,117)
Ending balance, shares at May. 31, 2023		3,350,000	2,533	6,129,670,789
Beginning balance, value at Feb. 28, 2023		$ 3,350	$ 101,619	$ 58,489	80,247,252	(112,253,711)	(31,843,001)
Beginning balance, shares at Feb. 28, 2023		3,350,000	2,533	5,848,741,599
Net income							(9,314,919)
Ending balance, value at Aug. 31, 2023		$ 3,350	$ 101,619	$ 70,399	87,445,715	(121,568,632)	(33,947,549)
Ending balance, shares at Aug. 31, 2023		3,350,000	2,533	7,039,806,793
Beginning balance, value at May. 31, 2023		$ 3,350	$ 101,619	$ 61,298	82,563,520	(116,808,904)	(34,079,117)
Beginning balance, shares at May. 31, 2023		3,350,000	2,533	6,129,670,789
Issuance of shares, net of issuance costs				$ 9,036	4,787,087		4,796,123
Issuance of shares, net of issuance costs, shares				903,636,004
Stock based compensation					50,713		50,713
Net income						(4,759,728)	(4,759,728)
Shares as payment for services				$ 65	44,395		44,460
Shares as payment for servises, shares				6,500,000
Ending balance, value at Aug. 31, 2023		$ 3,350	$ 101,619	$ 70,399	87,445,715	(121,568,632)	(33,947,549)
Ending balance, shares at Aug. 31, 2023		3,350,000	2,533	7,039,806,793
Beginning balance, value at Feb. 29, 2024		$ 3,350	$ 101,619	$ 92,388	92,565,513	(132,962,427)	(40,199,557)	[1]
Beginning balance, shares at Feb. 29, 2024		3,350,000	2,533	9,238,750,958
Issuance of shares, net of issuance costs				$ 10,802	2,671,791		2,682,593
Issuance of shares, net of issuance costs, shares				1,080,166,425
Stock based compensation					83,323		83,323
Net income						(4,194,359)	(4,194,359)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024						(4,175,535)	(4,175,535)
Issuance of Series B Preferred Shares	$ 360,000				(82,000)		(82,000)
Issuance of Series B Preferred Shares,shares	300
Series B Preferred Shares issued as commitment fee	$ 24,000				(24,000)		(24,000)
Series B Preferred Shares issued as commitment fee, shares	20
Series B Preferred shares issued as dividend	$ 2,568				(2,568)		(2,568)
Series B Preferred shares issued as dividend,shares	2
Redemption of Series B Preferred shares	$ (128,856)				28,856	(28,856)
Redemption of Series B Preferred shares,shares	(107)
Ending balance, value at May. 31, 2024	$ 257,712	$ 3,350	$ 101,619	$ 103,190	95,240,915	(141,361,177)	(45,912,103)
Ending balance, shares at May. 31, 2024	215	3,350,000	2,533	10,318,917,383
Beginning balance, value at Feb. 29, 2024		$ 3,350	$ 101,619	$ 92,388	92,565,513	(132,962,427)	$ (40,199,557)	[1]
Beginning balance, shares at Feb. 29, 2024		3,350,000	2,533	9,238,750,958
Issuance of shares, net of issuance costs, shares							2,410,777,227
Net income							$ (8,124,682)
Ending balance, value at Aug. 31, 2024		$ 3,350	$ 101,599	$ 117,067	99,993,641	(145,686,020)	(45,470,363)
Ending balance, shares at Aug. 31, 2024		3,350,000	2,513	11,706,671,042
Beginning balance, value at May. 31, 2024	$ 257,712	$ 3,350	$ 101,619	$ 103,190	95,240,915	(141,361,177)	(45,912,103)
Beginning balance, shares at May. 31, 2024	215	3,350,000	2,533	10,318,917,383
Issuance of shares, net of issuance costs				$ 13,306	4,478,054		4,491,360
Issuance of shares, net of issuance costs, shares				1,330,610,802
Stock based compensation					83,323		83,323
Net income						(3,930,323)	(3,930,323)
Series B Preferred shares issued as dividend	$ 2,620				(2,620)		(2,620)
Series B Preferred shares issued as dividend,shares	2
Redemption of Series B Preferred shares	$ (260,332)				60,333	(60,333)
Redemption of Series B Preferred shares,shares	(217)
Debt exchanged for common stock				$ 571	199,429		200,000
Debt exchanged for common stock, shares				57,142,857
Series F Preferred Shares exchanged for debt			$ (20)		(65,793)	(334,187)	(400,000)
Series F Preferred Shares exchanged for debt, shares			(20)
Ending balance, value at Aug. 31, 2024		$ 3,350	$ 101,599	$ 117,067	$ 99,993,641	$ (145,686,020)	$ (45,470,363)
Ending balance, shares at Aug. 31, 2024		3,350,000	2,513	11,706,671,042
[1] Derived from audited information

Condensed Consolidated Statement of Shareholders' Deficit (Unaudited) (Parenthetical) - USD ($)	3 Months Ended
	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023
Statement of Stockholders' Equity [Abstract]
Issuance cost of shares	$ 195,656	$ 116,046	$ 176,672	$ 81,285

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss	$ (8,124,682)	$ (9,314,919)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	645,311	358,983
Bad debts expense	11,995	24,730
Inventory provision	111,000
Reduction of right of use asset	63,821	58,220
Accretion of lease liability	61,159	66,864
Stock based compensation	166,646	228,434
Amortization of debt discounts	129,333	1,258,198
(Gain) loss on settlement of debt	6,520	(38,740)
Increase in related party accrued payroll and interest	22,151	54,230
Changes in operating assets and liabilities:
Accounts receivable	93,796	(20,377)
Prepaid expenses	75,146	(77,410)
Device parts inventory	(1,823,713)	(941,261)
Accounts payable and accrued expenses	6,989	16,775
Customer deposits	289,870	24,798
Deferred compensation for CEO	(505,000)
Operating lease liabilities	(118,383)	(125,083)
Current portion of deferred variable payment obligation for payments	410,887	125,457
Accrued interest payable	2,043,248	1,965,885
Net cash used in operating activities	(6,433,906)	(6,335,216)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets	(23,724)	(3,463)
Acquisition of trademarks	(4,144)
Convertible note receivable	(50,000)
Net cash used in investing activities	(77,868)	(3,463)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs	6,893,169	6,115,032
Proceeds from loans payable	350,000	1,050,000
Repayment of loans payable	(183,000)	(254,000)
Proceeds on issuance of Series B shares	278,000
Redemption of Series B shares	(389,188)
Net cash provided by financing activities	6,948,981	6,911,032
Net change in cash	437,207	572,353
Cash, beginning of period	105,926	939,759
Cash, end of period	543,133	1,512,112
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	185,705	9,892
Cash paid for income taxes
Noncash investing and financing activities:
Transfer from device parts inventory to revenue earning devices	1,781,083	889,230
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024	4,175,535
Discount applied to face value of loans		150,000
Exchange of Series F preferred stock for note payable	400,000
Exchange of note payable for common stock	200,000
Series B preferred shares issued as dividend	5,188
Series F warrants issued as part of debt		947,447
Shares issued for services		$ 44,460

GENERAL INFORMATION	6 Months Ended
	Aug. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL INFORMATION	1. GENERAL INFORMATION   Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).   Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.   On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.   The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

GOING CONCERN	6 Months Ended
	Aug. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	2. GOING CONCERN   The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.   For the six months ended August 31, 2024, the Company had negative cash flow from operating activities of $6,433,906. As of August 31, 2024, the Company has an accumulated deficit of $145,686,020, and negative working capital of $32,990,606 Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.   The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:   Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In July 2024, the Company entered into an equity financing agreement whereby an investor will purchase up to $30,000,000 of the Company’s common stock at a discount over a two-year period. There remains approximately $29 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

ACCOUNTING POLICIES	6 Months Ended
	Aug. 31, 2024
Accounting Policies [Abstract]
ACCOUNTING POLICIES	3. ACCOUNTING POLICIES   Basis of Presentation and Consolidation   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K/A as filed on May 29, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices Residential, Inc.. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the six months ended August 31, 2024, are not necessarily indicative of the results that may be expected for the entire year.   Use of Estimates   In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.   Reclassifications   Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.   Concentrations   Loans payable   At August 31, 2024 there were $33,163,345 of loans payable, $28,743,506 or 87% of these loans to companies controlled by one individual. At February 29, 2024 there were $32,796,345 of loans payable, $28,540,506 or 87% of these loans to companies controlled by the same individual.   Cash   The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.   Accounts Receivable   Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $48,000 and $68,000 provided as of August 31, 2024 and February 29, 2024, respectively. For the three months ended August 31, 2024, two customers account for 55% of total accounts receivable. For the three months ended August 31, 2023, two customers account for 37% of total accounts receivable.   Device Parts Inventory   Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of August 31, 2024 and February 29, 2024 there was a valuation reserve of $1,070,000 and $959,000, respectively.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   Revenue Earning Devices   Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.   Fixed Assets   Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.    Computer equipment and software   2 or 3 years Office equipment   4 years Manufacturing equipment   7 years Warehouse equipment   5 years Tooling   2 years Demo Devices   4 years Vehicles   3 years Leasehold improvements   5 years, the life of the lease   The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.   Research and Development   Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At August 31, 2024 and February 29, 2024, the Company had no deferred development costs.   Contingencies   Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.   Sales of Future Revenues   The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Does the agreement purport, in substance, to be a sale   ● Does the Company have continuing involvement in the generation of cash flows due the investor   ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets   ● Is the investors rate of return is implicitly limited by the terms of the agreement   ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return   ● Does the investor have recourse relating to payments due   In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.   Revenue Recognition   ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the six months ended August 31, 2024 , two customers accounted for 67% of total revenue (2023- 33%).   Income Taxes   Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements   Leases   Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.   Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.   Distinguishing Liabilities from Equity   The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.   Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.   Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.   Initial Measurement   The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.   Subsequent Measurement – Financial Instruments Classified as Liabilities   The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).   Fair Value of Financial Instruments   ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.   ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).   The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.         ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.         ● Level 3 – Inputs that are unobservable for the asset or liability.   Measured on a Recurring Basis   The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:       Amount at     Fair Value Measurement Using       Fair Value     Level 1     Level 2     Level 3   August 31, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000                                     February 29, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000     The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.   Earnings (Loss) per Share   Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.   Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   Recently Issued Accounting Pronouncements   Recently Issued Accounting Standards Not Yet Adopted   In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. The Company adopted the standard using a modified retrospective approach. The adjustment to the Company’s accumulated deficit at March 1, 2024 was $4,175,535 with a corresponding adjustment to loans payable.

REVENUE FROM CONTRACTS WITH CUSTOMERS	6 Months Ended
	Aug. 31, 2024
Revenue from Contract with Customer [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	4. REVENUE FROM CONTRACTS WITH CUSTOMERS   Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).   As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.   After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.   The following table presents revenues from contracts with customers disaggregated by product/service:       Three Months Ended     Three Months Ended     Six Months Ended     Six Months Ended       August 31, 2024     August 31, 2023     August 31, 2024     August 31, 2023   Device rental activities   $ 1,065,898     $ 343,543     $ 2,046,434     $ 581,692                                     Direct sales of goods and services     278,285       42,820       480,549       189,879     $ 1,344,183     $ 386,363     $ 2,526,983     $ 771,571       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

LEASES	6 Months Ended
	Aug. 31, 2024
Leases
LEASES	5. LEASES   We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.   There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.   Below is a summary of our lease assets and liabilities at August 31, 2024 and February 29, 2024.   Leases   Classification   August 31, 2024     February 29, 2024   Assets                     Operating   Operating Lease Assets   $ 1,070,511     $ 1,139,188   Liabilities                     Current                     Operating   Current Operating Lease Liability   $ 225,348     $ 237,653   Noncurrent                     Operating   Noncurrent Operating Lease Liabilities     837,844       889,360   Total lease liabilities       $ 1,063,192     $ 1,127,013     Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.   Rent expense and operating lease cost was $62,967 and $124,980 for the three and six months ended August 31, 2024, respectively, and $62,541 and $125,083 for the three and six months ended August 31, 2023, respectively.

REVENUE EARNING DEVICES	6 Months Ended
	Aug. 31, 2024
Revenue Earning Devices
REVENUE EARNING DEVICES	6. REVENUE EARNING DEVICES   Revenue earning devices consisted of the following:       August 31, 2024     February 29, 2024   Revenue earning devices   $ 5,163,379     $ 3,432,846   Less: Accumulated depreciation     (1,513,990 )     (952,844 )   $ 3,649,389     $ 2,480,002     During the three and six months ended August 31, 2024 the Company made total additions to revenue earning devices of $602,358 and $1,730,533, respectively, which were transfers from inventory. During the three and six months ended August 31, 2023 the Company made total additions to revenue earning devices of $341,042 and $785,464, respectively, which were transfers from inventory.   Depreciation and Amortization   Three Months Ended August 31, 2024     Three Months Ended August 31 2023     Six Months Ended August 31, 2024     Six Months Ended August 31 2023                             Cost of Goods Sold   $ 240,000     $ 111,575     $ 441,873     $ 208,539   Operating expenses     64,918       30,039       119,273       55,916   Total Depreciation and Amortization   $ 304,918     $ 141,614     $ 561,146     $ 264,455       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FIXED ASSETS	6 Months Ended
	Aug. 31, 2024
Property, Plant and Equipment [Abstract]
FIXED ASSETS	7. FIXED ASSETS   Fixed assets consisted of the following:       August 31, 2024     February 29, 2024   Automobile   $ 74,237     $ 74,237   Demo devices     244,900       194,352   Tooling     107,020       107,020   Machinery and equipment     8,825       8,825   Computer equipment     157,446       150,387   Office equipment     15,312       15,312   Furniture and fixtures     21,225       21,225   Warehouse equipment     36,305       19,639   Leasehold improvements     26,956       26,956       692,226       617,953   Less: Accumulated depreciation     (434,043 )     (349,878 )   $ 258,183     $ 268,075     During the three months ended August 31, 2024, the Company made additions of $22,097 of which $17,505 were transfers from inventory with remaining additions of $4,592. During the six months ended August 31, 2024, the Company made additions of $74,274 of which $50,550 were transfers from inventory with remaining additions of $23,724. During the three months ended August 31, 2023, the Company made additions of $75,057 which were transfers from inventory. During the six months ended August 31, 2023, the Company made additions of $107,230 of which $103,767 were transfers from inventory with remaining additions of $3,463.   Depreciation expense was $42,844 and $84,165 for the three and six months ended August 31, 2024, respectively, and $49,427 and $94,528 for the three and six months ended August 31, 2023, respectively.

DEFERRED VARIABLE PAYMENT OBLIGATION	6 Months Ended
	Aug. 31, 2024
Deferred Variable Payment Obligation
DEFERRED VARIABLE PAYMENT OBLIGATION	8. DEFERRED VARIABLE PAYMENT OBLIGATION   On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.   On May 9, 2019 the Company entered into two similar arrangements with two investors:     (1) The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.         (2) The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.   These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.   In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.   On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.   On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.   On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.   On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.   In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.   The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of August 31, 2024, the Company has accrued $1,315,264 in Payments of which $667,633 are in arrears. As of February 29, 2024, the Company has accrued approximately $904,377 in Payments, of which $542,176 is in arrears. No notices have been sent to the Company.   On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:     1) The rate payment was reduced from 14.25 % to 9.65 %   2) The asset disposition % (see below) was reduced from 31 % to 21%   In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of August 31, 2024, and February 29, 2024, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.   For both the three months and six months ended August 31, 2023 and year ended February 28, 2023, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both August 31, 2024 and February 29, 2024.

RELATED PARTY TRANSACTIONS	6 Months Ended
	Aug. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	9. RELATED PARTY TRANSACTIONS   For both the three months ended August 31, 2024 and August 31, 2023 , the Company had no repayments of net advances from its loan payable-related party At August 31, 2024 the loan payable-related party was $279,589 and $257,438 at February 29, 2024. Included in the balance due to the related party at August 31, 2024 is $203,057 of deferred salary and interest, $152,513 of which bears interest at 12%. As of February 29, 2024, included in the balance due to the related party is $140,013 of deferred salary all of which bears interest at 12%. The accrued interest included in loan at August 31, 2024 and February 29, 2024 was $41,549 and $32,468, respectively.   Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended August 31, 2023, the Company accrued $0 (2023-$62,000) and $0 (2023-$125,000) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At August 31, 2024 and February 29, 2024 there was $2,500,000 and $2,500,000 of incentive compensation payable.    At August 31, 2024 deferred compensation for CEO was $204,091. For the 6 months ended August 31, 2024,the net change was a decrease of $334,676 comprising of cash repayment of $505,000 offset by accruals and adjustments of $170,324. At February 29, 2024 deferred compensation for CEO was $538,767.   During the three months ended August 31, 2024 and 2023, the Company was charged $777,260 and $777,260, respectively for fees for research and development from a company partially owned by a principal shareholder.   During the six months ended August 31, 2024 and 2023, the Company was charged $1,289,830 and $1,659,275, respectively for fees for research and development from a company partially owned by a principal shareholder.

OTHER DEBT – VEHICLE LOAN	6 Months Ended
	Aug. 31, 2024
Other Debt Vehicle Loan
OTHER DEBT – VEHICLE LOAN	10. OTHER DEBT – VEHICLE LOAN   In December 2016, RAD entered into a vehicle loan for $47,704 secured by the vehicle. The loan is repayable over 5 years maturing November 9, 2021, and repayable $1,019 per month including interest and principal. In November 2017, RAD entered into another vehicle loan secured by the vehicle for $47,661. The loan is repayable over 5 years, maturing October 24, 2022 and repayable at $923 per month including interest and principal. The principal repayments made were $0 for both the year ended February 28, 2022 and February 28, 2021. Regarding the second vehicle loan, the vehicle was returned at the end of fiscal 2019 and the car was subsequently sold by the lender for proceeds of $21,907 which went to reduce the outstanding balance of the loan. A loss of $3,257 was recorded as well. A balance of $21,578 remains on this vehicle loan at both February 28, 2021 and February 29, 2020. For the first vehicle loan, the vehicle was retired in 2020, the proceeds of the disposal of $18,766 was applied against the balance of the loan with a $5,515 gain on the remaining asset value of $13,251. A balance of $16,944 remains on this vehicle loan at both February 28, 2022 and February 28, 2021. The remaining total balances of the amounts owed on the vehicle loans were $38,522 and $38,522 as of August 31, 2024 and February 29, 2024, respectively, of which all were classified as current.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

LOANS PAYABLE	6 Months Ended
	Aug. 31, 2024
Debt Disclosure [Abstract]
LOANS PAYABLE	11. LOANS PAYABLE   Loans payable at August 31, 2024 consisted of the following:                          Annual   Date   Maturity   Description       Principal     Interest Rate   July 18, 2016   July 18, 2017   Promissory note   (1)*   $ 3,500       22 % December 10, 2020   March 1, 2025   Promissory note   (2)     3,921,168       12 % December 10, 2020   March 1, 2025   Promissory note   (3)     2,754,338       12 % December 10, 2020   December 10, 2024   Promissory note   (4)     165,605       12 % December 14, 2020   March 1, 2027   Promissory note   (5)     310,375       12 % December 30, 2020   March 1, 2025   Promissory note   (6)     350,000       12 % January 1, 2021   March 1, 2025   Promissory note   (7)     25,000       12 % January 1, 2021   March 1, 2025   Promissory note   (8)     145,000       12 % January 14, 2021   March 1, 2025   Promissory note   (9)     550,000       12 % February 22, 2021   March 1, 2025   Promissory note   (10)     1,650,000       12 % March 1, 2021   March 1, 2025   Promissory note   (11)     6,000,000       12 % June 8, 2021   June 8, 2025   Promissory note   (12)     2,750,000       12 % July 12, 2021   July 26, 2026   Promissory note   (13)     3,740,360       7 % September 14, 2021   September 14, 2025   Promissory note   (14)     1,650,000       12 % July 28, 2022   March 1, 2025   Promissory note   (15)     170,000       15 % August 30, 2022   August 30,2025   Promissory note   (16)     3,000,000       15 % September 7, 2022   March 1, 2025   Promissory note   (17)     400,000       15 % September 8, 2022   March 1, 2025   Promissory note   (18)     475,000       15 % October 13, 2022   March 1, 2025   Promissory note   (19)     350,000       15 % October 28, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 9, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 10, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 15, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % January 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % February 6, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 5. 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 20, 23   October 31, 2026   Promissory note   (20)     400,000       15 % May 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % October 27, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % November 30, 2023   April 30, 2025   Purchase Agreement   (21)     203,000       35 % March 8, 2024   August 8, 2025   Purchase Agreement   (22)     350,000       35 % August 8, 2024   August 8, 2025   Exchange Agreement   (23)     200,000       12 %                 $ 33,163,346                                         Less: current portion of loans payable         (23,462,611 )         Less: discount on non-current loans payable         (413,071 )         Non-current loans payable, net of discount       $ 9,287,664                                 Current portion of loans payable       $ 23,462,611           Less: discount on current portion of loans payable         (88,993 )         Current portion of loans payable, net of discount       $ 23,373,618             * In default     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   On March 1, 2024 the Company adjusted the relative fair value unamortized discount on the above notes by $4,175,535 with a corresponding adjustment to accumulated deficit to apply ASU 2020-06.   (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.     (2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (4) This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.     (5) This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.     (6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $2,439 and $3,954, respectively, with an unamortized discount of $4,445 at August 31, 2024.     (7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     (8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $3,117 and $5,053, respectively, with an unamortized discount of $5,506 at August 31, 2024.     (10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $16,759 and $26,243, respectively, with an unamortized discount of $29,342 at August 31, 2024.     (11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025.     (12)  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $1,239 and $1,339, respectively, with an unamortized discount of $2,782 at August 31, 2024.     (13) This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2024 there were repayments of $9,000 and $36,000 , respectively on the note.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $14,301 and $19,928, respectively, with an unamortized discount of $46,918 at August 31, 2024. This note was extended to September 14, 2025.     (15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025.     (17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:       October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,455 and $7,065, respectively, with an unamortized discount of $40,827 at August 31, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (20) November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,294 and $7,097, respectively, with an unamortized discount of $41,029 at August 31, 2024.   November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,238 and $7,119, respectively, with an unamortized discount of $41,171 at August 31, 2024.   November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,262 and $7,076, respectively, with an unamortized discount of $40,900 at August 31, 2024.   January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,266 and $7,096, respectively, with an unamortized discount of $41,028 at August 31, 2024.   February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,314 and $7,130, respectively, with an unamortized discount of $41,174 at August 31, 2024.   April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,305 and $7,135, respectively, with an unamortized discount of $41,274 at August 31, 2024.   April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,484 and $7,186, respectively, with an unamortized discount of $41,591 at August 31, 2024.   May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $7,269 and $7,350, respectively, with an unamortized discount of $42,628 at August 31, 2024.   October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $5,876 and $7,163, respectively, with an unamortized discount of $41,448 at August 31, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (21) On November 30, 2023, the Company entered into an agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent.     (22) On March 8, 2024, the Company entered into another agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent.     (23) On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at August 31, 2024 is $200,000.

STOCKHOLDERS’ EQUITY (DEFICIT)	6 Months Ended
	Aug. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	12. STOCKHOLDERS’ EQUITY (DEFICIT)   Summary or Preferred Stock Activity   Series B Convertible, Redeemable Preferred Stock (Temporary Equity)   On April 27, 2024, in connection with a Share Purchase Agreement the Company created a new class Of Series B Convertible Redeemable Preferred Shares with 5,000 authorized shares. The Company received gross proceeds of $300,000 with net proceeds of $278,000 less $10,000 in legal fees and 12,000 in broker fees both charged against paid in capital. In addition, as a commitment fee the Company issued an additional 20 Series B Convertible Redeemable Preferred Shares, with a fair value of $24,000 charged to paid in capital. The shares have a redemption value of $1,200 per share. The Company must redeem one third of these shares in 30, days and each 30 days thereafter until all the shares are redeemed at 90 days. The Company must also pay an 8% dividend from issue date to redemption date. On May 30, June 28 and July 28, 2024 the Company then issued total dividends of 4.32 shares of Series B Convertible Redeemable Preferred Shares having a value of $5,188 and fully redeemed the outstanding 324 Series B shares for $389,189 including deemed dividends of $89,189 which represents the redemption value over the purchase cost of the shares.   At August 31, 2024 there are 0 Series B Convertible Redeemable Preferred Shares outstanding.   Series F Convertible Preferred Shares   During the six months ended August 31, 2024, a Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 12). The Company record an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.   Summary of Preferred Stock Warrant Activity       Number of Series F Preferred Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2023     939     $ 1.00       9.50   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     —       —       —   Outstanding at August 31, 2024     939     $ 1.00       9.20         ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   Summary of Common Stock Activity   The Company increased authorized common shares from 12,500,000,000 to 15,000,000,000 on October 4, 2024.   For the three months ended August 31, 2024, the Company issued 1,330,610,802 common shares with gross proceeds of $4,687,016 and net proceeds of $4,491,360 after issuance costs of $195,656. For the six months ended August 31, 2024, the Company issued 2,410,777,227 common shares with gross proceeds of $7,485,654 and net proceeds of $7,173,953 after issuance costs of $311,701. In addition, for the three and six months ended the Company issued 57,142,857 issuable shares as payment for $200,000 pf principle on a note payable. (see Note 12)   The table below represent the common shares issued, issuable and outstanding at August 31, 2024 and February 29, 2024:   Common shares   August 31, 2024     February 29, 2024   Issued     11,649,528,185       9,238,750,958   Issuable     57,142,857       —   Issued, issuable and outstanding     11,706,671,042       9,238,750,958     Summary of Common Stock Warrant Activity   For the three months and six months ended August 31, 2024 and August 31, 2023, the Company recorded a total of $83,323 and $50,713, and $166,646 and $103,434 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.       Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     300,595,661     $ 0.003       1.00   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     —       —       —   Outstanding at August 31, 2024     300,595,661     $ 0.003       0.49     Summary of Common Stock Option Activity -Employee Stock Options       Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     188,667,035     $ 0.02       4.10   Issued     —       —       —   Exercised     —       —       —   Forfeited, extinguished and cancelled     (3,011,029 )   $ 0.02       (4.60 ) Outstanding at August 31, 2024     185,656,006     $ 0.02       4.00       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Aug. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES   Litigation   Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.   The related legal costs are expensed as incurred.   Operating Lease   On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.   On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.   On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month. The Company paid a security deposit of $1,500.   On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.   The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $62,967 and $124,980 for the three and six months ended August 31, 2024, respectively, and 62,541 and $125,083 for the three and six months ended August 31, 2023, respectively.   Maturity of Lease Liabilities   Operating Leases   August 31, 2025   $ 225,348   August 31, 2026     225,348   August 31, 2027     214,970   August 31, 2028     207,558   August 31, 2029     207,558   August 31, 2030 and after     345,930   Total lease payments     1,426,712   Less: Interest     (363,520 ) Present value of lease liabilities   $ 1,063,192       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

EARNINGS (LOSS) PER SHARE	6 Months Ended
	Aug. 31, 2024
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	14. EARNINGS (LOSS) PER SHARE   The net income (loss) per common share amounts were determined as follows:       For the Three Months Ended     For the Six Months Ended       August 31,     August 31,       2024     2023     2024     2023   Numerator:                                 Net loss   $ (3,930,323 )   $ (4,759,728 )   $ (8,124,682 )   $ (9,314,919 ) Deduct : Dividend on Series B shares     (60,833 )     —       (89,689 )     —   Deduct: Deemed dividend on redemption of Series F shares     (334,187 )     —       (334,187 )     —   Net loss available to common shareholders     (4,325,343 )     (4,759,728 )     (8,548,558 )     (9,314,919 )                                   Denominator:                                 Weighted average shares – basic     11,181,863,976       6,568,957,612       10,531,991,040       6,266,833,467                                     Net income (loss) per share – basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )                                   Dilutive effect of common stock equivalents:                                 Convertible notes and accrued interest     —       —       —       —   Convertible Series F Preferred Shares     —       —       —       —   Stock options and warrants     —       —       —       —       —       —       —       —   Denominator:                                 Weighted average shares – diluted     11,181,863,976       6,568,957,612       10,531,991,040       6,266,833,467                                     Net income (loss) per share – diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )   The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2024 and 2032 were as follows:       For the Three Months Ended     For the Six Months Ended       August 31,     August 31,       2024     2023     2024     2023                             Convertible notes and accrued interest     —       —       —       —   Convertible Series F Preferred Shares     40,388,015,095       24,286,988,436       40,388,015,095       24,286,988,436   Stock options and warrants     486,251,667       433,767,451       486,251,667       433,767,451   Total     40,874,266,762       24,720,755,887       40,874,266,762       24,720,755,887

SUBSEQUENT EVENTS	6 Months Ended
	Aug. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	15. SUBSEQUENT EVENTS   Subsequent to August 31, 2024:   — The Company issued 335,000,000 common shares pursuant to a share purchase agreement for gross proceeds of $850,551, issuance costs of $37,097 and net proceeds of $813,454.   — The Board of Directors approved to increase authorized common shares from 12,500,000,000 to 15,000,000,000 on October 4, 2024.   — On September 24, 2024 a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet entered into on June 7, 2024. The Company and its counsel believe the claim is without merit and will contest it vigorously. Accordingly, the Company has made no accruals.

ACCOUNTING POLICIES (Policies)	6 Months Ended
	Aug. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K/A as filed on May 29, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., and Robotic Assistance Devices Residential, Inc.. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the six months ended August 31, 2024, are not necessarily indicative of the results that may be expected for the entire year.
Use of Estimates	Use of Estimates   In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.
Reclassifications	Reclassifications   Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.
Concentrations	Concentrations   Loans payable   At August 31, 2024 there were $33,163,345 of loans payable, $28,743,506 or 87% of these loans to companies controlled by one individual. At February 29, 2024 there were $32,796,345 of loans payable, $28,540,506 or 87% of these loans to companies controlled by the same individual.
Cash	Cash   The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.
Accounts Receivable	Accounts Receivable   Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $48,000 and $68,000 provided as of August 31, 2024 and February 29, 2024, respectively. For the three months ended August 31, 2024, two customers account for 55% of total accounts receivable. For the three months ended August 31, 2023, two customers account for 37% of total accounts receivable.
Device Parts Inventory	Device Parts Inventory   Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of August 31, 2024 and February 29, 2024 there was a valuation reserve of $1,070,000 and $959,000, respectively.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Revenue Earning Devices	Revenue Earning Devices   Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.
Fixed Assets	Fixed Assets   Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.    Computer equipment and software   2 or 3 years Office equipment   4 years Manufacturing equipment   7 years Warehouse equipment   5 years Tooling   2 years Demo Devices   4 years Vehicles   3 years Leasehold improvements   5 years, the life of the lease   The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.
Research and Development	Research and Development   Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At August 31, 2024 and February 29, 2024, the Company had no deferred development costs.
Contingencies	Contingencies   Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.
Sales of Future Revenues	Sales of Future Revenues   The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Does the agreement purport, in substance, to be a sale   ● Does the Company have continuing involvement in the generation of cash flows due the investor   ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets   ● Is the investors rate of return is implicitly limited by the terms of the agreement   ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return   ● Does the investor have recourse relating to payments due   In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.
Revenue Recognition	Revenue Recognition   ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the six months ended August 31, 2024 , two customers accounted for 67% of total revenue (2023- 33%).
Income Taxes	Income Taxes   Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements
Leases	Leases   Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.   Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.
Distinguishing Liabilities from Equity	Distinguishing Liabilities from Equity   The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.   Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.   Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.   Initial Measurement   The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.   Subsequent Measurement – Financial Instruments Classified as Liabilities   The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).
Fair Value of Financial Instruments	Fair Value of Financial Instruments   ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.   ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).   The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.         ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.         ● Level 3 – Inputs that are unobservable for the asset or liability.   Measured on a Recurring Basis   The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:       Amount at     Fair Value Measurement Using       Fair Value     Level 1     Level 2     Level 3   August 31, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000                                     February 29, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000     The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.
Earnings (Loss) per Share	Earnings (Loss) per Share   Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.   Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements   Recently Issued Accounting Standards Not Yet Adopted   In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. The Company adopted the standard using a modified retrospective approach. The adjustment to the Company’s accumulated deficit at March 1, 2024 was $4,175,535 with a corresponding adjustment to loans payable.

ACCOUNTING POLICIES (Tables)	6 Months Ended
	Aug. 31, 2024
Accounting Policies [Abstract]
SCHEDULE OF FIXED ASSETS STATED AT COST	Computer equipment and software   2 or 3 years Office equipment   4 years Manufacturing equipment   7 years Warehouse equipment   5 years Tooling   2 years Demo Devices   4 years Vehicles   3 years Leasehold improvements   5 years, the life of the lease
SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE	The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:       Amount at     Fair Value Measurement Using       Fair Value     Level 1     Level 2     Level 3   August 31, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000                                     February 29, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)	6 Months Ended
	Aug. 31, 2024
Revenue from Contract with Customer [Abstract]
SCHEDULE OF REVENUES FROM CONTRACTS WITH CUSTOMERS	The following table presents revenues from contracts with customers disaggregated by product/service:       Three Months Ended     Three Months Ended     Six Months Ended     Six Months Ended       August 31, 2024     August 31, 2023     August 31, 2024     August 31, 2023   Device rental activities   $ 1,065,898     $ 343,543     $ 2,046,434     $ 581,692                                     Direct sales of goods and services     278,285       42,820       480,549       189,879     $ 1,344,183     $ 386,363     $ 2,526,983     $ 771,571

LEASES (Tables)	6 Months Ended
	Aug. 31, 2024
Leases
SCHEDULE OF LEASE ASSETS AND LIABILITIES	Below is a summary of our lease assets and liabilities at August 31, 2024 and February 29, 2024.   Leases   Classification   August 31, 2024     February 29, 2024   Assets                     Operating   Operating Lease Assets   $ 1,070,511     $ 1,139,188   Liabilities                     Current                     Operating   Current Operating Lease Liability   $ 225,348     $ 237,653   Noncurrent                     Operating   Noncurrent Operating Lease Liabilities     837,844       889,360   Total lease liabilities       $ 1,063,192     $ 1,127,013

REVENUE EARNING DEVICES (Tables)	6 Months Ended
	Aug. 31, 2024
Revenue Earning Devices
SCHEDULE OF REVENUE EARNING DEVICES	Revenue earning devices consisted of the following:       August 31, 2024     February 29, 2024   Revenue earning devices   $ 5,163,379     $ 3,432,846   Less: Accumulated depreciation     (1,513,990 )     (952,844 )   $ 3,649,389     $ 2,480,002
SCHEDULE OF DEPRECIATION AND AMORTIZATION	Depreciation and Amortization   Three Months Ended August 31, 2024     Three Months Ended August 31 2023     Six Months Ended August 31, 2024     Six Months Ended August 31 2023                             Cost of Goods Sold   $ 240,000     $ 111,575     $ 441,873     $ 208,539   Operating expenses     64,918       30,039       119,273       55,916   Total Depreciation and Amortization   $ 304,918     $ 141,614     $ 561,146     $ 264,455

FIXED ASSETS (Tables)	6 Months Ended
	Aug. 31, 2024
Property, Plant and Equipment [Abstract]
SCHEDULE OF FIXED ASSETS	Fixed assets consisted of the following:       August 31, 2024     February 29, 2024   Automobile   $ 74,237     $ 74,237   Demo devices     244,900       194,352   Tooling     107,020       107,020   Machinery and equipment     8,825       8,825   Computer equipment     157,446       150,387   Office equipment     15,312       15,312   Furniture and fixtures     21,225       21,225   Warehouse equipment     36,305       19,639   Leasehold improvements     26,956       26,956       692,226       617,953   Less: Accumulated depreciation     (434,043 )     (349,878 )   $ 258,183     $ 268,075

LOANS PAYABLE (Tables)	6 Months Ended
	Aug. 31, 2024
Debt Disclosure [Abstract]
SCHEDULE OF LOANS PAYABLE	Loans payable at August 31, 2024 consisted of the following:                          Annual   Date   Maturity   Description       Principal     Interest Rate   July 18, 2016   July 18, 2017   Promissory note   (1)*   $ 3,500       22 % December 10, 2020   March 1, 2025   Promissory note   (2)     3,921,168       12 % December 10, 2020   March 1, 2025   Promissory note   (3)     2,754,338       12 % December 10, 2020   December 10, 2024   Promissory note   (4)     165,605       12 % December 14, 2020   March 1, 2027   Promissory note   (5)     310,375       12 % December 30, 2020   March 1, 2025   Promissory note   (6)     350,000       12 % January 1, 2021   March 1, 2025   Promissory note   (7)     25,000       12 % January 1, 2021   March 1, 2025   Promissory note   (8)     145,000       12 % January 14, 2021   March 1, 2025   Promissory note   (9)     550,000       12 % February 22, 2021   March 1, 2025   Promissory note   (10)     1,650,000       12 % March 1, 2021   March 1, 2025   Promissory note   (11)     6,000,000       12 % June 8, 2021   June 8, 2025   Promissory note   (12)     2,750,000       12 % July 12, 2021   July 26, 2026   Promissory note   (13)     3,740,360       7 % September 14, 2021   September 14, 2025   Promissory note   (14)     1,650,000       12 % July 28, 2022   March 1, 2025   Promissory note   (15)     170,000       15 % August 30, 2022   August 30,2025   Promissory note   (16)     3,000,000       15 % September 7, 2022   March 1, 2025   Promissory note   (17)     400,000       15 % September 8, 2022   March 1, 2025   Promissory note   (18)     475,000       15 % October 13, 2022   March 1, 2025   Promissory note   (19)     350,000       15 % October 28, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 9, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 10, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 15, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % January 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % February 6, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 5. 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 20, 23   October 31, 2026   Promissory note   (20)     400,000       15 % May 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % October 27, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % November 30, 2023   April 30, 2025   Purchase Agreement   (21)     203,000       35 % March 8, 2024   August 8, 2025   Purchase Agreement   (22)     350,000       35 % August 8, 2024   August 8, 2025   Exchange Agreement   (23)     200,000       12 %                 $ 33,163,346                                         Less: current portion of loans payable         (23,462,611 )         Less: discount on non-current loans payable         (413,071 )         Non-current loans payable, net of discount       $ 9,287,664                                 Current portion of loans payable       $ 23,462,611           Less: discount on current portion of loans payable         (88,993 )         Current portion of loans payable, net of discount       $ 23,373,618             * In default     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   On March 1, 2024 the Company adjusted the relative fair value unamortized discount on the above notes by $4,175,535 with a corresponding adjustment to accumulated deficit to apply ASU 2020-06.   (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.     (2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (4) This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.     (5) This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.     (6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $2,439 and $3,954, respectively, with an unamortized discount of $4,445 at August 31, 2024.     (7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     (8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $3,117 and $5,053, respectively, with an unamortized discount of $5,506 at August 31, 2024.     (10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $16,759 and $26,243, respectively, with an unamortized discount of $29,342 at August 31, 2024.     (11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025.     (12)  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $1,239 and $1,339, respectively, with an unamortized discount of $2,782 at August 31, 2024.     (13) This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2024 there were repayments of $9,000 and $36,000 , respectively on the note.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $14,301 and $19,928, respectively, with an unamortized discount of $46,918 at August 31, 2024. This note was extended to September 14, 2025.     (15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025.     (17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:       October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,455 and $7,065, respectively, with an unamortized discount of $40,827 at August 31, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (20) November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,294 and $7,097, respectively, with an unamortized discount of $41,029 at August 31, 2024.   November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,238 and $7,119, respectively, with an unamortized discount of $41,171 at August 31, 2024.   November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,262 and $7,076, respectively, with an unamortized discount of $40,900 at August 31, 2024.   January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,266 and $7,096, respectively, with an unamortized discount of $41,028 at August 31, 2024.   February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,314 and $7,130, respectively, with an unamortized discount of $41,174 at August 31, 2024.   April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,305 and $7,135, respectively, with an unamortized discount of $41,274 at August 31, 2024.   April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $6,484 and $7,186, respectively, with an unamortized discount of $41,591 at August 31, 2024.   May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $7,269 and $7,350, respectively, with an unamortized discount of $42,628 at August 31, 2024.   October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $5,876 and $7,163, respectively, with an unamortized discount of $41,448 at August 31, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (21) On November 30, 2023, the Company entered into an agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent.     (22) On March 8, 2024, the Company entered into another agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent.     (23) On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at August 31, 2024 is $200,000.

STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)	6 Months Ended
	Aug. 31, 2024
Equity [Abstract]
SUMMARY OF PREFERRED STOCK WARRANT ACTIVITY	Summary of Preferred Stock Warrant Activity       Number of Series F Preferred Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2023     939     $ 1.00       9.50   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     —       —       —   Outstanding at August 31, 2024     939     $ 1.00       9.20
SUMMARY OF COMMON SHARES ISSUED,ISSUABLE AND OUTSTANDING	The table below represent the common shares issued, issuable and outstanding at August 31, 2024 and February 29, 2024:   Common shares   August 31, 2024     February 29, 2024   Issued     11,649,528,185       9,238,750,958   Issuable     57,142,857       —   Issued, issuable and outstanding     11,706,671,042       9,238,750,958
SUMMARY OF COMMON STOCK WARRANT ACTIVITY	Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     300,595,661     $ 0.003       1.00   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     —       —       —   Outstanding at August 31, 2024     300,595,661     $ 0.003       0.49
SUMMARY OF COMMON STOCK OPTION ACTIVITY	Summary of Common Stock Option Activity -Employee Stock Options       Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     188,667,035     $ 0.02       4.10   Issued     —       —       —   Exercised     —       —       —   Forfeited, extinguished and cancelled     (3,011,029 )   $ 0.02       (4.60 ) Outstanding at August 31, 2024     185,656,006     $ 0.02       4.00

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Aug. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF MATURITY OF OPERATING LEASE LIABILITIES	Maturity of Lease Liabilities   Operating Leases   August 31, 2025   $ 225,348   August 31, 2026     225,348   August 31, 2027     214,970   August 31, 2028     207,558   August 31, 2029     207,558   August 31, 2030 and after     345,930   Total lease payments     1,426,712   Less: Interest     (363,520 ) Present value of lease liabilities   $ 1,063,192

EARNINGS (LOSS) PER SHARE (Tables)	6 Months Ended
	Aug. 31, 2024
Earnings Per Share [Abstract]
SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE	The net income (loss) per common share amounts were determined as follows:       For the Three Months Ended     For the Six Months Ended       August 31,     August 31,       2024     2023     2024     2023   Numerator:                                 Net loss   $ (3,930,323 )   $ (4,759,728 )   $ (8,124,682 )   $ (9,314,919 ) Deduct : Dividend on Series B shares     (60,833 )     —       (89,689 )     —   Deduct: Deemed dividend on redemption of Series F shares     (334,187 )     —       (334,187 )     —   Net loss available to common shareholders     (4,325,343 )     (4,759,728 )     (8,548,558 )     (9,314,919 )                                   Denominator:                                 Weighted average shares – basic     11,181,863,976       6,568,957,612       10,531,991,040       6,266,833,467                                     Net income (loss) per share – basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )                                   Dilutive effect of common stock equivalents:                                 Convertible notes and accrued interest     —       —       —       —   Convertible Series F Preferred Shares     —       —       —       —   Stock options and warrants     —       —       —       —       —       —       —       —   Denominator:                                 Weighted average shares – diluted     11,181,863,976       6,568,957,612       10,531,991,040       6,266,833,467                                     Net income (loss) per share – diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )
SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS	The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2024 and 2032 were as follows:       For the Three Months Ended     For the Six Months Ended       August 31,     August 31,       2024     2023     2024     2023                             Convertible notes and accrued interest     —       —       —       —   Convertible Series F Preferred Shares     40,388,015,095       24,286,988,436       40,388,015,095       24,286,988,436   Stock options and warrants     486,251,667       433,767,451       486,251,667       433,767,451   Total     40,874,266,762       24,720,755,887       40,874,266,762       24,720,755,887

GENERAL INFORMATION (Details Narrative) - shares	Aug. 28, 2017	Aug. 31, 2024	Feb. 29, 2024	Jul. 25, 2017
Restructuring Cost and Reserve [Line Items]
Common stock, issued		11,706,671,042	9,238,750,958
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Common stock, issued				10,000
Robotic Assistance Devices LLC [Member] | Series E Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	3,350,000
Robotic Assistance Devices LLC [Member] | Series F Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	2,450

GOING CONCERN (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended				6 Months Ended
	Jul. 31, 2024	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Mar. 01, 2024	Feb. 29, 2024	[1]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash flow from operating activities						$ 6,433,906	$ 6,335,216
Accumulated deficit		$ 145,686,020				145,686,020		$ (4,175,535)	$ 132,962,427
Working capital		(32,990,606)				(32,990,606)
Purchase of common stock		195,656	$ 116,046	$ 176,672	$ 81,285
Common stock net of discount		29,000,000				29,000,000
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase of common stock		$ 195,656				$ 311,701
Common Stock [Member] | Equity Financing Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase of common stock	$ 30,000,000
[1] Derived from audited information

SCHEDULE OF FIXED ASSETS STATED AT COST (Details)	Aug. 31, 2024
Computer Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Computer Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	7 years
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years
Tooling [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years

SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details) - USD ($)	Aug. 31, 2024	Feb. 29, 2024
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 2,500,000	$ 2,500,000
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 2,500,000	$ 2,500,000

ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	12 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Feb. 29, 2024		Mar. 01, 2024
Product Information [Line Items]
Loans payable	$ 33,163,345		$ 33,163,345	$ 32,796,345
Allowance for doubtful accounts receivable	48,000		48,000	68,000
Inventory valuation reserves	$ 1,070,000		$ 1,070,000	959,000
Depreciation life	48 months		48 months
Deferred development costs	$ 0		$ 0	0
Description of deferred tax assets and liabilities			The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Accumulated deficit	$ (145,686,020)		$ (145,686,020)	(132,962,427)	[1]	$ 4,175,535
Two Customer [Member]
Product Information [Line Items]
Percentage of revenue	67.00%	33.00%	67.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customer [Member]
Product Information [Line Items]
Percentage of accounts receivable	55.00%	37.00%
Controller [Member]
Product Information [Line Items]
Loans additions			$ 28,743,506	$ 28,540,506
Loans percentage	87.00%		87.00%	87.00%
[1] Derived from audited information

SCHEDULE OF REVENUES FROM CONTRACTS WITH CUSTOMERS (Details) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Revenue from Contract with Customer [Abstract]
Device rental activities	$ 1,065,898	$ 343,543	$ 2,046,434	$ 581,692
Direct sales of goods and services	278,285	42,820	480,549	189,879
Revenue	$ 1,344,183	$ 386,363	$ 2,526,983	$ 771,571

SCHEDULE OF LEASE ASSETS AND LIABILITIES (Details) - USD ($)	Aug. 31, 2024	Feb. 29, 2024
Leases
Operating Lease Assets	$ 1,070,511	$ 1,139,188
Current Operating Lease Liability	225,348	237,653	[1]
Noncurrent Operating Lease Liabilities	837,844	889,360	[1]
Total lease liabilities	$ 1,063,192	$ 1,127,013
[1] Derived from audited information

LEASES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Leases
Weighted average remaining lease term	12 months		12 months
Incremental borrowing rate	10.00%		10.00%
Rent	$ 62,967	$ 62,541	$ 124,980	$ 125,083

SCHEDULE OF REVENUE EARNING DEVICES (Details) - USD ($)	Aug. 31, 2024	Feb. 29, 2024
Revenue Earning Devices
Revenue earning devices	$ 5,163,379	$ 3,432,846
Less: Accumulated depreciation	(1,513,990)	(952,844)
Total	$ 3,649,389	$ 2,480,002

SCHEDULE OF DEPRECIATION AND AMORTIZATION (Details) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Revenue Earning Devices
Cost of Goods Sold	$ 240,000	$ 111,575	$ 441,873	$ 208,539
Operating expenses	64,918	30,039	119,273	55,916
Total Depreciation and Amortization	$ 304,918	$ 141,614	$ 561,146	$ 264,455

REVENUE EARNING DEVICES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Revenue earning	$ 602,358	$ 341,042	$ 1,730,533	$ 785,464

SCHEDULE OF FIXED ASSETS (Details) - USD ($)	Aug. 31, 2024	Feb. 29, 2024
Property, Plant and Equipment [Line Items]
Fixed assets gross	$ 692,226	$ 617,953
Less: Accumulated depreciation	(434,043)	(349,878)
Fixed assets, net of accumulated depreciation	258,183	268,075	[1]
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	74,237	74,237
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	244,900	194,352
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	107,020	107,020
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	8,825	8,825
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	157,446	150,387
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	15,312	15,312
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	21,225	21,225
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	36,305	19,639
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	$ 26,956	$ 26,956
[1] Derived from audited information

FIXED ASSETS (Details Narrative) - Robotic Assistance Devices LLC [Member] - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Restructuring Cost and Reserve [Line Items]
Additions to fixed assets	$ 22,097	$ 75,057	$ 74,274	$ 107,230
Assets transfers from inventory	17,505	75,057	50,550	103,767
Remaining additions to fixed assets	4,592		23,724	3,463
Depreciation expense	$ 42,844	$ 49,427	$ 84,165	$ 94,528

DEFERRED VARIABLE PAYMENT OBLIGATION (Details Narrative) - USD ($)										3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 01, 2021	Aug. 27, 2020	Jul. 01, 2020	Apr. 22, 2020	Feb. 29, 2020	Dec. 30, 2019	Nov. 18, 2019	May 09, 2019	Feb. 01, 2019	Aug. 31, 2023	May 31, 2021	Aug. 31, 2024	Aug. 31, 2023	Feb. 28, 2023	Feb. 29, 2024		May 31, 2020
Maximum amount of debt												$ 33,163,346
Accrued payment												1,315,264			$ 904,377
Default on payments												667,633			542,176
Aggregate investment	$ 1,925,000
Total payment obligation												$ 2,525,000			2,525,000	[1]
Payment receive										$ 0			$ 0	$ 0
Investors [Member]
Maximum amount of debt									$ 900,000
Percentage of exchange rate									9.00%
Debt instrument, date of first required payment					Feb. 29, 2020
Maximum amount of debt					$ 900,000
Investor One [Member]
Maximum amount of debt					400,000			$ 400,000
Percentage of exchange rate								4.00%
Investor Two [Member]
Maximum amount of debt					50,000			$ 50,000
Percentage of exchange rate								1.11%
Investor [Member]
Maximum amount of debt			$ 800,000	$ 100,000		$ 100,000
Percentage of exchange rate		14.25%	2.75%	1.00%		1.00%	2.25%
Maximum amount of debt		$ 1,925,000			109,000		$ 225,000
Description of variable payments terms			If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.									These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.
Description of disposition price		The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.										the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.
Advance amount																	$ 116,000
Investor received advanced					$ 50,000
Percentage of exchange rate		10.00%
Total payment obligation												$ 2,525,000			$ 2,525,000
Investor [Member] | Series F Preferred Stock [Member]
Shares issued	40
Warrants issued	367
Warrants term	5 years
Exercise price	$ 1.00
Warrants exercised											38
Fair value of warrants											$ 33,015,214
Investor [Member] | Maximum [Member]
Percentage of exchange rate	14.25%
Percentage of total asset disposition price	31.00%
Investor [Member] | Minimum [Member]
Percentage of exchange rate	9.65%
Percentage of total asset disposition price	21.00%
Investor [Member] | Agreement One [Member]
Maximum amount of debt		$ 900,000
Investor [Member] | Agreement Two [Member]
Maximum amount of debt		225,000
Investor [Member] | Agreement Three [Member]
Maximum amount of debt		$ 800,000
[1] Derived from audited information

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024
Related Party Transaction [Line Items]
Loan payable-related party	$ 33,163,345		$ 33,163,345		$ 32,796,345
Interest accrued related party			41,549		32,468
Deferred compensation	204,091		204,091		538,767	[1]
Decrease of deferred compensation			(505,000)
Consulting fees for research and development	777,260	$ 777,260	1,289,830	1,659,275
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Incentive compensation plan payable			2,500,000		2,500,000
Deferred compensation	$ 204,091		204,091		538,767
Decrease of deferred compensation			334,676
Repayment of deferred compensation			505,000
Accruals and adjustments of deferred compensation			$ 170,324
Chief Executive Officer [Member] | Series G Preferred Stock [Member]
Related Party Transaction [Line Items]
Share price	$ 1,000		$ 1,000
Chief Executive Officer [Member] | Employment Agreement [Member]
Related Party Transaction [Line Items]
Incentive compensation plan payable	$ 0	$ 62,000	$ 0	$ 125,000
Related Party [Member]
Related Party Transaction [Line Items]
Loan payable-related party	279,589		279,589		257,438
Balance due to related party	$ 203,057		203,057		$ 140,013
Interest expenses			$ 152,513
Percentage of interest expense due to related party			12.00%		12.00%
[1] Derived from audited information

OTHER DEBT – VEHICLE LOAN (Details Narrative) - USD ($)		1 Months Ended		6 Months Ended
	Feb. 29, 2020	Nov. 30, 2017	Dec. 31, 2016	Aug. 31, 2024	Feb. 29, 2024	Feb. 28, 2022	Feb. 28, 2021
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile				$ 33,163,346
Fair value of warrants						$ 0	$ 0
Robotic Assistance Devices LLC [Member] | Secured Debt [Member]
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile		$ 47,661	$ 47,704
Term of debt		5 years	5 years
Payment of debt interest and principal		$ 923	$ 1,019
Maturity date		Oct. 24, 2022
Outstanding balance of the loan		$ 21,907
Loss on sale of vehicle				3,257
Current portion vehicle loan	$ 21,578						21,578
Proceeds of disposal of vehicle offset against vehicle loan	18,766
Remaining asset value	5,515
Reclassification of fixed assets to vehicle for disposal	$ 13,251
Long-term vehicle loan						$ 16,944	$ 16,944
Total vehicle loan				$ 38,522	$ 38,522

SCHEDULE OF LOANS PAYABLE (Details)	6 Months Ended
	Aug. 31, 2024 USD ($)
Short-Term Debt [Line Items]
Debt instrument, face amount	$ 33,163,346
Less: current portion of loans payable	(23,462,611)
Less: discount on non-current loans payable	(413,071)
Non-current loans payable, net of discount	9,287,664
Current portion of loans payable	23,462,611
Less: discount on current portion of loans payable	(88,993)
Current portion of loans payable, net of discount	$ 23,373,618
Promissory Note Payable One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jul. 18, 2016	[1],[2]
Debt Instrument, Maturity Date	Jul. 18, 2017	[1],[2]
Debt instrument, face amount	$ 3,500	[1],[2]
Annual interest rate	22.00%	[1],[2]
Promissory Note Payable Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 10, 2020	[3]
Debt Instrument, Maturity Date	Mar. 01, 2025	[3]
Debt instrument, face amount	$ 3,921,168	[3]
Annual interest rate	12.00%	[3]
Promissory Note Payable Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 10, 2020	[4]
Debt Instrument, Maturity Date	Mar. 01, 2025	[4]
Debt instrument, face amount	$ 2,754,338	[4]
Annual interest rate	12.00%	[4]
Promissory Note Payable Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 10, 2020	[5]
Debt Instrument, Maturity Date	Dec. 10, 2024	[5]
Debt instrument, face amount	$ 165,605	[5]
Annual interest rate	12.00%	[5]
Promissory Note Payable Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 14, 2020	[6]
Debt Instrument, Maturity Date	Mar. 01, 2027	[6]
Debt instrument, face amount	$ 310,375	[6]
Annual interest rate	12.00%	[6]
Promissory Note Payable Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 30, 2020	[7]
Debt Instrument, Maturity Date	Mar. 01, 2025	[7]
Debt instrument, face amount	$ 350,000	[7]
Annual interest rate	12.00%	[7]
Promissory Note Payable Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 01, 2021	[8]
Debt Instrument, Maturity Date	Mar. 01, 2025	[8]
Debt instrument, face amount	$ 25,000	[8]
Annual interest rate	12.00%	[8]
Promissory Note Payable Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 01, 2021	[9]
Debt Instrument, Maturity Date	Mar. 01, 2025	[9]
Debt instrument, face amount	$ 145,000	[9]
Annual interest rate	12.00%	[9]
Promissory Note Payable Nine [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 14, 2021	[10]
Debt Instrument, Maturity Date	Mar. 01, 2025	[10]
Debt instrument, face amount	$ 550,000	[10]
Annual interest rate	12.00%	[10]
Promissory Note Payable Ten [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Feb. 22, 2021	[11]
Debt Instrument, Maturity Date	Mar. 01, 2025	[11]
Debt instrument, face amount	$ 1,650,000	[11]
Annual interest rate	12.00%	[11]
Promissory Note Payable Eleven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Mar. 01, 2021	[12]
Debt Instrument, Maturity Date	Mar. 01, 2025	[12]
Debt instrument, face amount	$ 6,000,000	[12]
Annual interest rate	12.00%	[12]
Promissory Note Payable Twelve [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jun. 08, 2021	[13]
Debt Instrument, Maturity Date	Jun. 08, 2025	[13]
Debt instrument, face amount	$ 2,750,000	[13]
Annual interest rate	12.00%	[13]
Promissory Note Payable Thirteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jul. 12, 2021	[14]
Debt Instrument, Maturity Date	Jul. 26, 2026	[14]
Debt instrument, face amount	$ 3,740,360	[14]
Annual interest rate	7.00%	[14]
Promissory Note Payable Fourteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Sep. 14, 2021	[15]
Debt Instrument, Maturity Date	Sep. 14, 2025	[15]
Debt instrument, face amount	$ 1,650,000	[15]
Annual interest rate	12.00%	[15]
Promissory Note Payable Fifteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jul. 28, 2022	[16]
Debt Instrument, Maturity Date	Mar. 01, 2025	[16]
Debt instrument, face amount	$ 170,000	[16]
Annual interest rate	15.00%	[16]
Promissory Note Payable Sixteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Aug. 30, 2022	[17]
Debt Instrument, Maturity Date	Aug. 30, 2025	[17]
Debt instrument, face amount	$ 3,000,000	[17]
Annual interest rate	15.00%	[17]
Promissory Note Payable Seventeen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Sep. 07, 2022	[18]
Debt Instrument, Maturity Date	Mar. 01, 2025	[18]
Debt instrument, face amount	$ 400,000	[18]
Annual interest rate	15.00%	[18]
Promissory Note Payable Eighteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Sep. 08, 2022	[19]
Debt Instrument, Maturity Date	Mar. 01, 2025	[19]
Debt instrument, face amount	$ 475,000	[19]
Annual interest rate	15.00%	[19]
Promissory Note Payable Nineteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Oct. 13, 2022	[20]
Debt Instrument, Maturity Date	Mar. 01, 2025	[20]
Debt instrument, face amount	$ 350,000	[20]
Annual interest rate	15.00%	[20]
Promissory Note Payable Twenty [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Oct. 28, 2022	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 09, 2022	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 10, 2022	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 15, 2022	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 11, 2023	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Feb. 06, 2023	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Apr. 05, 2023	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Apr. 20, 2023	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	May 11, 2023	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Twenty Nine [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Oct. 27, 2023	[21]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21]
Debt instrument, face amount	$ 400,000	[21]
Annual interest rate	15.00%	[21]
Promissory Note Payable Thirty [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 30, 2023	[22]
Debt Instrument, Maturity Date	Apr. 30, 2025	[22]
Debt instrument, face amount	$ 203,000	[22]
Annual interest rate	35.00%	[22]
Promissory Note Payable Thirty One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Mar. 08, 2024	[23]
Debt Instrument, Maturity Date	Aug. 08, 2025	[23]
Debt instrument, face amount	$ 350,000	[23]
Annual interest rate	35.00%	[23]
Promissory Note Payable Thirty Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Aug. 08, 2024	[24]
Debt Instrument, Maturity Date	Aug. 08, 2025	[24]
Debt instrument, face amount	$ 200,000	[24]
Annual interest rate	12.00%	[24]
[1] In default [2] This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. [3] This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [4] This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [5] This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. [6] This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. [7] The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $2,439 and $3,954, respectively, with an unamortized discount of $4,445 at August 31, 2024. [8] This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [9] This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [10] The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $3,117 and $5,053, respectively, with an unamortized discount of $5,506 at August 31, 2024. [11] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $16,759 and $26,243, respectively, with an unamortized discount of $29,342 at August 31, 2024. [12] The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. [13]  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $1,239 and $1,339, respectively, with an unamortized discount of $2,782 at August 31, 2024. [14] This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2024 there were repayments of $9,000 and $36,000 , respectively on the note. [15] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $14,301 and $19,928, respectively, with an unamortized discount of $46,918 at August 31, 2024. This note was extended to September 14, 2025. [16] Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [17] A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. [18] Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [19] Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [20] Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [21] On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows: [22] On November 30, 2023, the Company entered into an agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent. [23] On March 8, 2024, the Company entered into another agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent. [24] On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at August 31, 2024 is $200,000.

SCHEDULE OF LOANS PAYABLE (Details) (Parenthetical) - USD ($)										1 Months Ended	3 Months Ended				6 Months Ended		12 Months Ended
		Aug. 22, 2024	Aug. 08, 2024	Mar. 08, 2024	Feb. 29, 2024	Nov. 30, 2023	Nov. 29, 2023	Nov. 28, 2023	Oct. 28, 2022	Jul. 31, 2024	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024	Feb. 28, 2022	Mar. 01, 2024	Oct. 27, 2023	May 11, 2023	Apr. 20, 2023	Apr. 05, 2023	Feb. 06, 2023	Jan. 11, 2023	Nov. 15, 2022	Nov. 10, 2022	Nov. 09, 2022
Short-Term Debt [Line Items]
Conversion of convertible securities											$ 200,000
Amortization of debt expense															$ 129,333	$ 1,258,198
Loans payable					$ 32,796,345						33,163,345				33,163,345		$ 32,796,345
Number of common stock issued, shares											4,491,360	$ 2,682,593	$ 4,796,123	$ 1,318,909
Promissory Note Payable Two [Member]
Short-Term Debt [Line Items]
Convertible notes payable											2,683,357				2,683,357
Accrued interest											1,237,811				1,237,811
Conversion of convertible securities															3,921,168
Notes payable											$ 3,921,168				$ 3,921,168
Purchase of warrants											450,000,000				450,000,000
Exercise price											$ 0.002				$ 0.002
Fair value											$ 990,000				$ 990,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same
Annual interest rate	[1]										12.00%				12.00%
Promissory Note Payable Three [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 1,460,794				$ 1,460,794
Accrued interest											1,593,544				1,593,544
Conversion of convertible securities															3,054,338
Notes payable											$ 3,054,338				$ 3,054,338
Purchase of warrants											250,000,000				250,000,000
Exercise price											$ 0.002				$ 0.002
Fair value											$ 550,000				$ 550,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same
Total payments																	300,000
Annual interest rate	[2]										12.00%				12.00%
Promissory Note Payable Four [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 103,180				$ 103,180
Accrued interest											62,425				62,425
Conversion of convertible securities															165,605
Notes payable											$ 165,605				$ 165,605
Purchase of warrants											80,000,000				80,000,000
Exercise price											$ 0.002				$ 0.002
Fair value											$ 176,000				$ 176,000
Debt instrument maturity date description					The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense
Interest expenses					$ 22,958
Annual interest rate	[3]										12.00%				12.00%
Promissory Note Payable Five [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 235,000				$ 235,000
Accrued interest											75,375				75,375
Conversion of convertible securities															310,375
Notes payable											$ 310,375				$ 310,375
Purchase of warrants											25,000,000				25,000,000
Exercise price											$ 0.002				$ 0.002
Fair value											$ 182,500				$ 182,500
Annual interest rate	[4]										12.00%				12.00%
Promissory Note Payable Six [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 4,445				$ 4,445				$ 8,399
Purchase of warrants											50,000,000				50,000,000
Exercise price											$ 0.025				$ 0.025
Fair value											$ 271,250				$ 271,250
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same
Prepaid expense											350,000				350,000
Original issue discount											$ 35,000				$ 35,000
Warrants term											3 years				3 years
Debt discount											$ 271,250				$ 271,250				65,092
Amortization of debt expense											$ 2,439				$ 3,954
Annual interest rate	[5]										12.00%				12.00%
Promissory Note Payable Seven [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 9,200				$ 9,200
Accrued interest											6,944				6,944
Conversion of convertible securities															16,144
Notes payable											$ 25,000				$ 25,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same
Annual interest rate	[6]										12.00%				12.00%
Promissory Note Payable Eight [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 79,500				$ 79,500
Accrued interest											28,925				28,925
Conversion of convertible securities															108,425
Notes payable											$ 145,000				$ 145,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same
Annual interest rate	[7]										12.00%				12.00%
Promissory Note Payable Nine [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 5,506				$ 5,506				10,559
Purchase of warrants											50,000,000				50,000,000
Exercise price											$ 0.025				$ 0.025
Fair value											$ 380,174				$ 380,174
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same
Prepaid expense											550,000				550,000
Original issue discount											$ 250,000				$ 250,000
Warrants term											3 years				3 years
Debt discount											$ 380,174				$ 380,174				80,284
Amortization of debt expense											$ 3,117				$ 5,053
Annual interest rate	[8]										12.00%				12.00%
Promissory Note Payable Ten [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 29,342				$ 29,342				55,585
Purchase of warrants											100,000,000				100,000,000			50,000,000
Exercise price											$ 0.135				$ 0.135			$ 0.0164
Fair value											$ 1,342,857				$ 1,342,857
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same
Interest expenses																		$ 950,000
Prepaid expense											1,650,000				1,650,000
Original issue discount											$ 150,000				$ 150,000
Warrants term											3 years				3 years			3 years
Debt discount											$ 1,342,857				$ 1,342,857				497,614
Amortization of debt expense											$ 16,759				$ 26,243
Annual interest rate	[9]										12.00%				12.00%
Promissory Note Payable Eleven [Member]
Short-Term Debt [Line Items]
Notes payable											$ 6,000,000				$ 6,000,000
Purchase of warrants											300,000,000				300,000,000			150,000,000
Exercise price											$ 0.135				$ 0.135			$ 0.0164
Fair value											$ 4,749,005				$ 4,749,005
Interest expenses																		$ 2,850,000
Original issue discount											$ 600,000				$ 600,000
Warrants term											3 years				3 years			3 years
Debt discount											$ 4,749,005				$ 4,749,005
Cash proceeds															$ 5,400,000
Annual interest rate	[10]										12.00%				12.00%
Promissory Note Payable Twelve [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 2,782				$ 2,782				4,121
Purchase of warrants											170,000,000				170,000,000			85,000,000
Exercise price											$ 0.064				$ 0.064			$ 0.0164
Fair value											$ 2,035,033				$ 2,035,033
Interest expenses																		$ 1,615,000
Original issue discount											$ 50,000				$ 50,000
Warrants term											3 years				3 years			3 years
Debt discount											$ 2,035,033				$ 2,035,033				33,547
Amortization of debt expense											$ 1,239				1,339
Cash proceeds															$ 2,750,000
Annual interest rate	[11]										12.00%				12.00%
Promissory Note Payable Thirteen [Member]
Short-Term Debt [Line Items]
Prepaid expense											$ 4,000,160				$ 4,000,160
Repayment of notes											$ 9,000				$ 36,000
Annual interest rate	[12]										7.00%				7.00%
Promissory Note Payable Thirteen [Member] | Director [Member] | Series F Preferred Stock [Member]
Short-Term Debt [Line Items]
Conversion of convertible securities, shares															184
Promissory Note Payable Fourteen [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 46,918				$ 46,918				66,846
Purchase of warrants											250,000,000				250,000,000
Exercise price											$ 0.037				$ 0.037
Fair value											$ 1,284,783				$ 1,284,783
Prepaid expense											1,650,000				1,650,000
Original issue discount											$ 150,000				$ 150,000
Warrants term											3 years				3 years
Debt discount											$ 1,284,783				$ 1,284,783				572,549
Amortization of debt expense											$ 14,301				$ 19,928
Annual interest rate	[13]										12.00%				12.00%
Promissory Note Payable Fifteen [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 20,000				$ 20,000
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized
Prepaid expense											$ 170,000				$ 170,000
Annual interest rate	[14]										15.00%				15.00%
Promissory Note Payable Sixteen [Member]
Short-Term Debt [Line Items]
Notes payable											$ 3,000,000				$ 3,000,000
Fair value											2,960,500				2,960,500
Debt discount											$ 39,500				$ 39,500				11,535
Class of Warrant or Right, Outstanding											955,000,000				955,000,000
Annual interest rate	[15]										15.00%				15.00%
Promissory Note Payable Seventeen [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 50,000				$ 50,000
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized
Prepaid expense											$ 400,000				$ 400,000
Annual interest rate	[16]										15.00%				15.00%
Promissory Note Payable Eighteen [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 75,000				$ 75,000
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized
Prepaid expense											$ 475,000				$ 475,000
Annual interest rate	[17]										15.00%				15.00%
Promissory Note Payable Nineteen [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 50,000				$ 50,000
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized
Prepaid expense											$ 350,000				$ 350,000
Annual interest rate	[18]										15.00%				15.00%
Promissory Note Payable Twenty [Member]
Short-Term Debt [Line Items]
Unamortized discount									$ 500,000
Notes payable									400,000
Original issue discount					$ 4,000,000				50,000								$ 4,000,000
Cash proceeds									$ 350,000
Annual interest rate	[19]										15.00%				15.00%
Promissory Note Payable Twenty [Member] | Series F Warrants [Member] | October 31, 2033 [Member]
Short-Term Debt [Line Items]
Purchase of warrants									61
Promissory Note Payable Twenty [Member] | Lender [Member]
Short-Term Debt [Line Items]
Loans payable									$ 4,000,000
Promissory Note Payable Twenty [Member] | Lender [Member] | Series F Preferred Stock [Member]
Short-Term Debt [Line Items]
Shares issued									329
Promissory Note Payable Twenty [Member] | Lender [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Shares issued									1
Promissory Note Payable Twenty One [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 40,827				$ 40,827				47,892
Fair value									$ 299,399
Original issue discount									50,000
Debt discount																			286,775
Amortization of debt expense											$ 6,455				$ 7,065
Annual interest rate	[19]										15.00%				15.00%
Loans payable									$ 400,000
Promissory Note Payable Twenty One [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants									61
Promissory Note Payable Twenty One [Member] | Series F Preferred Shares [Member]
Short-Term Debt [Line Items]
Conversion of convertible securities, shares									1
Promissory Note Payable Twenty Two [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,029				$ 41,029				48,126
Fair value																												$ 299,750
Original issue discount																												50,000
Debt discount																			288,513
Amortization of debt expense											$ 6,294				$ 7,097
Annual interest rate	[19]										15.00%				15.00%
Loans payable																												$ 400,000
Promissory Note Payable Twenty Two [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																												61
Promissory Note Payable Twenty Three [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,171				$ 41,171				48,290
Fair value																											$ 302,020
Original issue discount																											50,000
Debt discount																			291,694
Amortization of debt expense											$ 6,238				$ 7,119
Annual interest rate	[19]										15.00%				15.00%
Loans payable																											$ 400,000
Promissory Note Payable Twenty Three [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																											61
Promissory Note Payable Twenty Four [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 40,900				$ 40,900				47,976
Fair value																										$ 299,959
Original issue discount																										50,000
Debt discount																			287,814
Amortization of debt expense											$ 6,262				$ 7,076
Annual interest rate	[19]										15.00%				15.00%
Loans payable																										$ 400,000
Promissory Note Payable Twenty Four [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																										61
Promissory Note Payable Twenty Five [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,028				$ 41,028				48,124
Fair value																									$ 299,959
Original issue discount																									50,000
Debt discount																			286,813
Amortization of debt expense											$ 6,266				$ 7,096
Annual interest rate	[19]										15.00%				15.00%
Loans payable																									$ 400,000
Promissory Note Payable Twenty Five [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																									61
Promissory Note Payable Twenty Six [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,174				$ 41,174				48,294
Fair value																								$ 299,959
Original issue discount																								50,000
Debt discount																			288,342
Amortization of debt expense											$ 6,314				$ 7,130
Annual interest rate	[19]										15.00%				15.00%
Loans payable																								$ 400,000
Promissory Note Payable Twenty Six [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																								61
Promissory Note Payable Twenty Seven [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,274				$ 41,274				48,409
Fair value																							$ 296,245
Original issue discount																							50,000
Debt discount																			286,821
Amortization of debt expense											$ 6,305				$ 7,135
Annual interest rate	[19]										15.00%				15.00%
Loans payable																							$ 400,000
Promissory Note Payable Twenty Seven [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																							61
Promissory Note Payable Twenty Eight [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,591				$ 41,591				48,777
Fair value																						$ 302,219
Original issue discount																						50,000
Debt discount																			294,824
Amortization of debt expense											$ 6,484				$ 7,186
Annual interest rate	[19]										15.00%				15.00%
Loans payable																						$ 400,000
Promissory Note Payable Twenty Nine [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 42,628				$ 42,628				49,978
Fair value																					$ 348,983
Original issue discount																					50,000
Debt discount																			348,831
Amortization of debt expense											$ 7,269				$ 7,350
Annual interest rate	[19]										15.00%				15.00%
Loans payable																					$ 400,000
Promissory Note Payable Twenty Nine [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																					61
Promissory Note Payable Thirty [Member]
Short-Term Debt [Line Items]
Unamortized discount											$ 41,448				$ 41,448				48,611
Fair value																				$ 261,759
Original issue discount																				50,000
Debt discount																			254,487
Amortization of debt expense											$ 5,876				$ 7,163
Annual interest rate	[20]										35.00%				35.00%
Loans payable																				$ 400,000
Promissory Note Payable Thirty [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																				61
Promissory Note Payable Thirty One [Member]
Short-Term Debt [Line Items]
Annual interest rate	[21]										35.00%				35.00%
Promissory Note Payable Thirty One [Member] | Lender [Member]
Short-Term Debt [Line Items]
Accrued interest										$ 53,000
Total payments						$ 477,750
Annual interest rate						35.00%
Loans payable						$ 350,000
Monthly payments						thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750
Default rate						15.00%
Repayment of debt										$ 147,000
Promissory Note Payable Thirty Two [Member]
Short-Term Debt [Line Items]
Annual interest rate	[22]										12.00%				12.00%
Promissory Note Payable Thirty Two [Member] | Lender [Member]
Short-Term Debt [Line Items]
Total payments				$ 477,750
Annual interest rate				35.00%
Loans payable				$ 350,000
Monthly payments				thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750
Default rate				15.00%
Promissory Note Payable Thirty Three [Member] | Lender [Member]
Short-Term Debt [Line Items]
Notes payable			$ 400,000								$ 200,000				$ 200,000
Conversion of convertible securities, shares			20
Outstanding payable		$ 200,000
Number of common stock issued, shares		$ 57,142,857
Accounting Standards Update 2020-06 [Member]
Short-Term Debt [Line Items]
Unamortized discount																			$ 4,175,535
[1] This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [2] This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [3] This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. [4] This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. [5] The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $2,439 and $3,954, respectively, with an unamortized discount of $4,445 at August 31, 2024. [6] This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [7] This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [8] The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $3,117 and $5,053, respectively, with an unamortized discount of $5,506 at August 31, 2024. [9] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $16,759 and $26,243, respectively, with an unamortized discount of $29,342 at August 31, 2024. [10] The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. [11]  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $1,239 and $1,339, respectively, with an unamortized discount of $2,782 at August 31, 2024. [12] This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2024 there were repayments of $9,000 and $36,000 , respectively on the note. [13] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and six months ended August 31, 2024, the Company recorded amortization expense of $14,301 and $19,928, respectively, with an unamortized discount of $46,918 at August 31, 2024. This note was extended to September 14, 2025. [14] Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [15] A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. [16] Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [17] Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [18] Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [19] On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows: [20] On November 30, 2023, the Company entered into an agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent. [21] On March 8, 2024, the Company entered into another agreement where the lender will buy pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent. [22] On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at August 31, 2024 is $200,000.

SUMMARY OF PREFERRED STOCK WARRANT ACTIVITY (Details) - Series F Preferred Warrants [Member] - $ / shares	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Class of Stock [Line Items]
Number of Series F Preferred Warrants, Outstanding Beginning balance	939
Weighted Average Exercise Price, Oustanding Beginng balance	$ 1.00
Weighted Average Remaining Years, Outstanding	9 years 2 months 12 days	9 years 6 months
Number of Series F Preferred Warrants, Issued
Weighted Average Exercise Price, Issued
Number of Series F Preferred Warrants, Exercised
Weighted Average Exercise Price, Exercised
Number of Series F Preferred Warrants,Forfieted and cancelled
Weighted Average Exercise Price,Forfieted and cancelled
Number of Series F Preferred Warrants, Outstanding Beginning balance	939	939
Weighted Average Exercise Price, Oustanding ending balance	$ 1.00	$ 1.00

SUMMARY OF COMMON SHARES ISSUED,ISSUABLE AND OUTSTANDING (Details) - shares	Aug. 31, 2024	Feb. 29, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	11,706,671,042	9,238,750,958
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	11,649,528,185	9,238,750,958
Issuable	57,142,857
Issued, issuable and outstanding	11,706,671,042	9,238,750,958

SUMMARY OF COMMON STOCK WARRANT ACTIVITY (Details) - Common Stock Warrant [Member] - $ / shares	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Class of Stock [Line Items]
Number of Series F Preferred Warrants, Outstanding Beginning balance	300,595,661
Weighted Average Exercise Price, Oustanding Beginng balance	$ 0.003
Weighted Average Remaining Years, Outstanding	5 months 26 days	1 year
Number of Series F Preferred Warrants, Issued
Weighted Average Exercise Price, Issued
Number of Series F Preferred Warrants, Exercised
Weighted Average Exercise Price, Exercised
Number of Series F Preferred Warrants, Forfeited and cancelled
Weighted Average Exercise Price,Forfieted and cancelled
Number of Series F Preferred Warrants, Outstanding Beginning balance	300,595,661	300,595,661
Weighted Average Exercise Price, Oustanding ending balance	$ 0.003	$ 0.003

SUMMARY OF COMMON STOCK OPTION ACTIVITY (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	6 Months Ended	12 Months Ended
	Aug. 31, 2024	Feb. 29, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock options, Outstanding, Beginning Balance	188,667,035
Weighted Average Exercise Price, Beginning Balance	$ 0.02
Weighted Average Remaining Years, Outstanding	4 years	4 years 1 month 6 days
Number of Stock Options, Issued
Weighted Average Exercise Price, Issued
Number of Stock Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Stock Options, Forfeited, extinguished and cancelled	(3,011,029)
Weighted Average Exercise Price, Forfeited, extinguished and cancelled	$ 0.02
Weighted Average Remaining Contractual Term, Forfeited, extinguished and cancelled	4 years 7 months 6 days
Number of Stock Options, Outstanding, Ending Balance	185,656,006	188,667,035
Weighted Average Exercise Price, Ending Balance	$ 0.02	$ 0.02

STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)					3 Months Ended				6 Months Ended
	Jul. 28, 2024	Jun. 28, 2024	May 30, 2024	Apr. 27, 2024	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Oct. 04, 2024	Oct. 03, 2024	Feb. 29, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized					15,535,000				15,535,000				15,535,000
Gross proceeds									$ 278,000
Shares issuable									2,410,777,227
Preferred stock dividend	$ 5,188	$ 5,188	$ 5,188
Reedemable preferred stock dividend, shares	324	324	324
Reedemable preferred stock dividend	$ 389,189	$ 389,189	$ 389,189
Deemed dividends	$ 89,189	$ 89,189	$ 89,189
Deeemed dividend on redemption of Series F shares					$ 334,187				$ 334,187
Common stock, authorized					15,000,000,000				15,000,000,000				15,000,000,000
Net proceeds from issuance of common stock									$ 6,893,169	6,115,032
Payments of stock issuance costs					$ 195,656	$ 116,046	$ 176,672	$ 81,285
Share based compensation									$ 166,646	228,434
Series B Convertible Redeemable Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock dividend rate percentage				8.00%
Preferred stock dividend	$ 4.32	$ 4.32	$ 4.32
Temporary shares outstanding					0				0
Preferred Stock [Member] | Series B Convertible Redeemable Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized				5,000
Gross proceeds				$ 300,000
Net proceeds				278,000
Legal fees				10,000
Broker fees				$ 12,000
Shares issuable				20
Fair value charged in paid in capital				$ 24,000
Preferred stock redemption price per share				$ 1,200
Preferred Stock [Member] | Series F Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Seies F convertible preferred share									20
Notes payable					$ 400,000				$ 400,000
Preferred stock par value shares					$ 20				$ 20
Seies F convertible preferred shares									$ 65,793
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issuable					1,330,610,802	1,080,166,425	903,636,004	280,929,190
Reedemable preferred stock dividend
Gross proceeds from issuance of common stock					4,687,016				7,485,654
Net proceeds from issuance of common stock					4,491,360				7,173,953
Payments of stock issuance costs					195,656				311,701
Debt instrument carrying amount					$ 200,000				$ 200,000
Common Stock [Member] | Subsequent Event [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, authorized											15,000,000,000	12,500,000,000
Common Stock Issuable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issuable					57,142,857				57,142,857
Common Stock Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation					$ 83,323		$ 50,713		$ 166,646	$ 103,434

SCHEDULE OF MATURITY OF OPERATING LEASE LIABILITIES (Details) - USD ($)	Aug. 31, 2024	Feb. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
August 31, 2025	$ 225,348
August 31, 2026	225,348
August 31, 2027	214,970
August 31, 2028	207,558
August 31, 2029	207,558
August 31, 2030 and after	345,930
Total lease payments	1,426,712
Less: Interest	(363,520)
Present value of lease liabilities	$ 1,063,192	$ 1,127,013

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)					3 Months Ended		6 Months Ended
	Feb. 05, 2024	Jan. 28, 2022	Sep. 30, 2021	Mar. 10, 2021	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Feb. 29, 2024	[1]
Product Liability Contingency [Line Items]
Minimum base rent					$ 62,967	$ 62,541	$ 124,980	$ 125,083
Security deposit					15,880		15,880		$ 15,880
Rent expense and operating lease cost					$ 62,967	$ 62,541	$ 124,980	$ 125,083
10 Years Lease Agreement [Member]
Product Liability Contingency [Line Items]
Description of operating lease				the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month
10 Years Lease Agreement [Member] | Ferndale, Michigan [Member]
Product Liability Contingency [Line Items]
Minimum base rent				$ 15,880
Security deposit				$ 15,880
3-Years Lease Agreement [Member]
Product Liability Contingency [Line Items]
Description of operating lease	On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month.		On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month.
Minimum base rent	$ 1,223		$ 1,538
Rental down payment	$ 9,357		$ 18,462
2-Years Lease Agreement [Member] | Santa Ana, California [Member]
Product Liability Contingency [Line Items]
Description of operating lease		On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month.
Minimum base rent		$ 1,500
Security deposit		$ 1,500
[1] Derived from audited information

SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE (Details) - USD ($)	3 Months Ended				6 Months Ended
	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss	$ (3,930,323)	$ (4,194,359)	$ (4,759,728)	$ (4,555,193)	$ (8,124,682)	$ (9,314,919)
Deduct : Dividend on Series B shares	(60,833)				(89,689)
Deduct: Deemed dividend on redemption of Series F shares	$ (334,187)				$ (334,187)
Net loss available to common shareholders	$ (4,325,343)		$ (4,759,728)		$ (8,548,558)	$ (9,314,919)
Weighted average shares – basic	11,181,863,976		6,568,957,612		10,531,991,040	6,266,833,467
Net income (loss) per share – basic	$ (0.00)		$ (0.00)		$ (0.00)	$ (0.00)
Total
Weighted average shares – diluted	11,181,863,976		6,568,957,612		10,531,991,040	6,266,833,467
Net income (loss) per share – diluted	$ (0.00)		$ (0.00)		$ (0.00)	$ (0.00)
Convertible Notes and Accrued Interest [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Convertible Series F Preferred Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total

SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS (Details) - shares	3 Months Ended		6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023	Aug. 31, 2024	Aug. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	40,874,266,762	24,720,755,887	40,874,266,762	24,720,755,887
Convertible Notes and Accrued Interest [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total
Convertible Series F Preferred Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	40,388,015,095	24,286,988,436	40,388,015,095	24,286,988,436
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	486,251,667	433,767,451	486,251,667	433,767,451

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended				6 Months Ended
	Oct. 15, 2024	Aug. 31, 2024	May 31, 2024	Aug. 31, 2023	May 31, 2023	Aug. 31, 2024	Aug. 31, 2023	Oct. 04, 2024	Oct. 03, 2024	Feb. 29, 2024
Subsequent Event [Line Items]
Number of shares issued						2,410,777,227
Gross proceeds						$ 6,893,169	$ 6,115,032
Issuance cost of shares		$ 195,656	$ 116,046	$ 176,672	$ 81,285
Common stock shares authorized		15,000,000,000				15,000,000,000				15,000,000,000
Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued		1,330,610,802	1,080,166,425	903,636,004	280,929,190
Gross proceeds		$ 4,491,360				$ 7,173,953
Issuance cost of shares		$ 195,656				$ 311,701
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Common stock shares authorized								15,000,000,000	12,500,000,000
Subsequent Event [Member] | Share Purchase Agreement [Member]
Subsequent Event [Line Items]
Number of shares issued	335,000,000
Gross proceeds	$ 850,551
Issuance cost of shares	37,097
Cash proceeds	$ 813,454

---